Gene list of this dataset (1726 genes)
GeneID | Symbol | Name | Genetic location | Original ID1 | Original ID2 |
8086 | AAAS | achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A) | 12q13 | AAAS | |
65985 | AACS | acetoacetyl-CoA synthetase | 12q24.31 | AACS | |
16 | AARS | alanyl-tRNA synthetase | 16q22 | AARS | |
10157 | AASS | aminoadipate-semialdehyde synthase | 7q31.3 | AASS | |
19 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 9q31.1 | ABCA1 | |
5243 | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 7q21.1 | ABCB1 | |
8647 | ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 2q24 | ABCB11 | |
5244 | ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | 7q21.1 | ABCB4 | |
4363 | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | 16p13.1 | ABCC1 | |
10257 | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | 13q32 | ABCC4 | |
225 | ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | 12q11-q12 | ABCD2 | |
9619 | ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | 21q22.3 | ABCG1 | |
9429 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | 4q22 | ABCG2 | |
64240 | ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1) | 2p21 | ABCG5 | |
64241 | ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2) | 2p21 | ABCG8 | |
10152 | ABI2 | abl interactor 2 | 2q33 | ABI2 | |
25 | ABL1 | c-abl oncogene 1, receptor tyrosine kinase | 9q34.1 | ABL1 | |
27 | ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 1q24-q25 | ABL2 | |
28 | ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 9q34.1-q34.2 | ABO | |
29 | ABR | active BCR-related gene | 17p13.3 | ABR | |
36 | ACADSB | acyl-Coenzyme A dehydrogenase, short/branched chain | 10q26.13 | ACADSB | |
84680 | ACCS | 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) | 11p11 | ACCS | |
65057 | ACD | adrenocortical dysplasia homolog (mouse) | 16q22.1 | ACD | |
1636 | ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 17q23.3 | ACE | |
59272 | ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | Xp22 | ACE2 | |
43 | ACHE | acetylcholinesterase (Yt blood group) | 7q22 | ACHE | |
47 | ACLY | ATP citrate lyase | 17q12-q21 | ACLY | |
57001 | ACN9 | ACN9 homolog (S. cerevisiae) | 7q21.3 | ACN9 | |
48 | ACO1 | aconitase 1, soluble | 9p22-q32|9p21.1 | ACO1 | |
51 | ACOX1 | acyl-Coenzyme A oxidase 1, palmitoyl | 17q24-q25|17q25.1 | ACOX1 | |
52 | ACP1 | acid phosphatase 1, soluble | 2p25 | ACP1 | |
93650 | ACPT | acid phosphatase, testicular | 19q13.4 | ACPT | |
49 | ACR | acrosin | 22q13-qter|22q13.33 | ACR | |
60 | ACTB | actin, beta | 7p15-p12 | ACTB | |
81 | ACTN4 | actinin, alpha 4 | 19q13 | ACTN4 | |
95 | ACY1 | aminoacylase 1 | 3p21.1 | ACY1 | |
100 | ADA | adenosine deaminase | 20q12-q13.11 | ADA | |
6868 | ADAM17 | ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) | 2p25 | ADAM17 | |
11093 | ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | 9q34 | ADAMTS13 | |
103 | ADAR | adenosine deaminase, RNA-specific | 1q21.1-q21.2 | ADAR | |
113451 | ADC | arginine decarboxylase | 1p33-p34.3 | ADC | |
113 | ADCY7 | adenylate cyclase 7 | 16q12-q13 | ADCY7 | |
118 | ADD1 | adducin 1 (alpha) | 4p16.3 | ADD1 | |
119 | ADD2 | adducin 2 (beta) | 2p14-p13 | ADD2 | |
124 | ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 4q21-q23 | ADH1A | |
125 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 4q21-q23 | ADH1B | |
126 | ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 4q21-q23 | ADH1C | |
127 | ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 4q21-q24|4q22 | ADH4 | |
128 | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide | 4q21-q25 | ADH5 | |
130 | ADH6 | alcohol dehydrogenase 6 (class V) | 4q23 | ADH6 | |
131 | ADH7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | 4q23-q24 | ADH7 | |
137872 | ADHFE1 | alcohol dehydrogenase, iron containing, 1 | 8q13.1 | ADHFE1 | |
51094 | ADIPOR1 | adiponectin receptor 1 | 1p36.13-q41 | ADIPOR1 | |
79602 | ADIPOR2 | adiponectin receptor 2 | 12p13.31 | ADIPOR2 | |
133 | ADM | adrenomedullin | 11p15.4 | ADM | |
23394 | ADNP | activity-dependent neuroprotector homeobox | 20q13.13 | ADNP | |
84890 | ADO | 2-aminoethanethiol (cysteamine) dioxygenase | 10q21.2 | ADO | |
150 | ADRA2A | adrenergic, alpha-2A-, receptor | 10q24-q26 | ADRA2A | |
151 | ADRA2B | adrenergic, alpha-2B-, receptor | 2p13-q13 | ADRA2B | |
152 | ADRA2C | adrenergic, alpha-2C-, receptor | 4p16 | ADRA2C | |
153 | ADRB1 | adrenergic, beta-1-, receptor | 10q24-q26 | ADRB1 | |
154 | ADRB2 | adrenergic, beta-2-, receptor, surface | 5q31-q32 | ADRB2 | |
155 | ADRB3 | adrenergic, beta-3-, receptor | 8p12-p11.2 | ADRB3 | |
159 | ADSS | adenylosuccinate synthase | 1cen-q12 | ADSS | |
166 | AES | amino-terminal enhancer of split | 19p13.3 | AES | |
174 | AFP | alpha-fetoprotein | 4q11-q13 | AFP | |
175 | AGA | aspartylglucosaminidase | 4q32-q33 | AGA | |
177 | AGER | advanced glycosylation end product-specific receptor | 6p21.3 | AGER | |
178 | AGL | amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III) | 1p21 | AGL | |
8540 | AGPS | alkylglycerone phosphate synthase | 2q31.2 | AGPS | |
181 | AGRP | agouti related protein homolog (mouse) | 16q22 | AGRP | |
183 | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1q42-q43 | AGT | |
185 | AGTR1 | angiotensin II receptor, type 1 | 3q21-q25 | AGTR1 | |
196 | AHR | aryl hydrocarbon receptor | 7p15 | AHR | |
57491 | AHRR | aryl-hydrocarbon receptor repressor | 5p15.3 | AHRR | |
9049 | AIP | aryl hydrocarbon receptor interacting protein | 11q13.3 | AIP | |
203 | AK1 | adenylate kinase 1 | 9q34.1 | AK1 | |
204 | AK2 | adenylate kinase 2 | 1p34 | AK2 | |
50808 | AK3 | adenylate kinase 3 | 9p24.1-p24.3 | AK3 | |
11214 | AKAP13 | A kinase (PRKA) anchor protein 13 | 15q24-q25 | AKAP13 | |
80709 | AKNA | AT-hook transcription factor | 9q32 | AKNA | |
10327 | AKR1A1 | aldo-keto reductase family 1, member A1 (aldehyde reductase) | 1p33-p32 | AKR1A1 | |
231 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) | 7q35 | AKR1B1 | |
57016 | AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) | 7q33 | AKR1B10 | |
1645 | AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 10p15-p14 | AKR1C1 | |
1646 | AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 10p15-p14 | AKR1C2 | |
1109 | AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 10p15-p14 | AKR1C4 | |
8574 | AKR7A2 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | 1p35.1-p36.23 | AKR7A2 | |
207 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 14q32.32|14q32.32 | AKT1 | |
208 | AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 19q13.1-q13.2 | AKT2 | |
210 | ALAD | aminolevulinate, delta-, dehydratase | 9q33.1 | ALAD | |
211 | ALAS1 | aminolevulinate, delta-, synthase 1 | 3p21.1 | ALAS1 | |
213 | ALB | albumin | 4q11-q13 | ALB | |
216 | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 9q21.13 | ALDH1A1 | |
8854 | ALDH1A2 | aldehyde dehydrogenase 1 family, member A2 | 15q22.1 | ALDH1A2 | |
220 | ALDH1A3 | aldehyde dehydrogenase 1 family, member A3 | 15q26.3 | ALDH1A3 | |
219 | ALDH1B1 | aldehyde dehydrogenase 1 family, member B1 | 9p11.1 | ALDH1B1 | |
217 | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 12q24.2 | ALDH2 | |
218 | ALDH3A1 | aldehyde dehydrogenase 3 family, memberA1 | 17p11.2 | ALDH3A1 | |
224 | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 | 17p11.2 | ALDH3A2 | |
8659 | ALDH4A1 | aldehyde dehydrogenase 4 family, member A1 | 1p36 | ALDH4A1 | |
7915 | ALDH5A1 | aldehyde dehydrogenase 5 family, member A1 (succinate-semialdehyde dehydrogenase) | 6p22.2-p22.3 | ALDH5A1 | |
4329 | ALDH6A1 | aldehyde dehydrogenase 6 family, member A1 | 14q24.3 | ALDH6A1 | |
501 | ALDH7A1 | aldehyde dehydrogenase 7 family, member A1 | 5q31 | ALDH7A1 | |
223 | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 | 1q23.1 | ALDH9A1 | |
230 | ALDOC | aldolase C, fructose-bisphosphate | 17cen-q12 | ALDOC | |
85365 | ALG2 | asparagine-linked glycosylation 2 homolog (S. cerevisiae, alpha-1,3-mannosyltransferase) | 9q22.33 | ALG2 | |
238 | ALK | anaplastic lymphoma receptor tyrosine kinase | 2p23 | ALK | |
60529 | ALX4 | aristaless-like homeobox 4 | 11p11.2 | ALX4 | |
259 | AMBP | alpha-1-microglobulin/bikunin precursor | 9q32-q33 | AMBP | |
262 | AMD1 | adenosylmethionine decarboxylase 1 | 6q21-q22 | AMD1 | |
268 | AMH | anti-Mullerian hormone | 19p13.3 | AMH | |
81693 | AMN | amnionless homolog (mouse) | 14q32.3 | AMN | |
196394 | AMN1 | antagonist of mitotic exit network 1 homolog (S. cerevisiae) | 12p11.21 | AMN1 | |
273 | AMPH | amphiphysin | 7p14-p13 | AMPH | |
275 | AMT | aminomethyltransferase | 3p21.2-p21.1 | AMT | |
283 | ANG | angiogenin, ribonuclease, RNase A family, 5 | 14q11.1-q11.2 | ANG | |
288 | ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 10q21 | ANK3 | |
56172 | ANKH | ankylosis, progressive homolog (mouse) | 5p15.1 | ANKH | |
255239 | ANKK1 | ankyrin repeat and kinase domain containing 1 | 11q23.1 | ANKK1 | |
302 | ANXA2 | annexin A2 | 15q21-q22 | ANXA2 | |
316 | AOX1 | aldehyde oxidase 1 | 2q33 | AOX1 | |
324 | APC | adenomatous polyposis coli | 5q21-q22 | APC | |
325 | APCS | amyloid P component, serum | 1q21-q23 | APCS | |
328 | APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 14q11.2-q12 | APEX1 | |
335 | APOA1 | apolipoprotein A-I | 11q23-q24 | APOA1 | |
336 | APOA2 | apolipoprotein A-II | 1q21-q23 | APOA2 | |
337 | APOA4 | apolipoprotein A-IV | 11q23 | APOA4 | |
116519 | APOA5 | apolipoprotein A-V | 11q23 | APOA5 | |
338 | APOB | apolipoprotein B (including Ag(x) antigen) | 2p24-p23 | APOB | |
345 | APOC3 | apolipoprotein C-III | 11q23.1-q23.2 | APOC3 | |
347 | APOD | apolipoprotein D | 3q26.2-qter | APOD | |
348 | APOE | apolipoprotein E | 19q13.2 | APOE | |
351 | APP | amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) | 21q21.2|21q21.3 | APP | |
358 | AQP1 | aquaporin 1 (Colton blood group) | 7p14 | AQP1 | |
359 | AQP2 | aquaporin 2 (collecting duct) | 12q12-q13 | AQP2 | |
360 | AQP3 | aquaporin 3 (Gill blood group) | 9p13 | AQP3 | |
361 | AQP4 | aquaporin 4 | 18q11.2-q12.1 | AQP4 | |
362 | AQP5 | aquaporin 5 | 12q13 | AQP5 | |
367 | AR | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) | Xq11.2-q12 | AR | |
369 | ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | Xp11.4-p11.2 | ARAF | |
23237 | ARC | activity-regulated cytoskeleton-associated protein | 8q24.3 | ARC | |
374 | AREG | amphiregulin (schwannoma-derived growth factor) | 4q13-q21 | AREG | |
375 | ARF1 | ADP-ribosylation factor 1 | 1q42 | ARF1 | |
383 | ARG1 | arginase, liver | 6q23 | ARG1 | |
384 | ARG2 | arginase, type II | 14q24.1-q24.3 | ARG2 | |
23365 | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 11q23.3 | ARHGEF12 | |
405 | ARNT | aryl hydrocarbon receptor nuclear translocator | 1q21 | ARNT | |
10777 | ARPP-21 | - | 3p22.3 | ARPP-21 | |
409 | ARRB2 | arrestin, beta 2 | 17p13 | ARRB2 | |
410 | ARSA | arylsulfatase A | 22q13.31-qter|22q13.33 | ARSA | |
347527 | ARSH | arylsulfatase family, member H | Xp22.33 | ARSH | |
79827 | ASAM | - | 11q24.1 | ASAM | |
435 | ASL | argininosuccinate lyase | 7cen-q11.2 | ASL | |
444 | ASPH | aspartate beta-hydroxylase | 8q12.1 | ASPH | |
54829 | ASPN | asporin | 9q22 | ASPN | |
466 | ATF1 | activating transcription factor 1 | 12q13 | ATF1 | |
1386 | ATF2 | activating transcription factor 2 | 2q32 | ATF2 | |
468 | ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 22q13.1 | ATF4 | |
22926 | ATF6 | activating transcription factor 6 | 1q22-q23 | ATF6 | |
472 | ATM | ataxia telangiectasia mutated | 11q22-q23 | ATM | |
494 | ATP3 | ATPase, Mg++ transporting | - | ATP3 | |
495 | ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | 19q13.1 | ATP4A | |
496 | ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | 13q34 | ATP4B | |
516 | ATP5G1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) | 17q21.32 | ATP5G1 | |
517 | ATP5G2 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) | 12q13.13 | ATP5G2 | |
518 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) | 2q31.1 | ATP5G3 | |
545 | ATR | ataxia telangiectasia and Rad3 related | 3q22-q24 | ATR | |
549 | AUH | AU RNA binding protein/enoyl-Coenzyme A hydratase | 9q22.31 | AUH | |
10677 | AVIL | advillin | 12q14.1 | AVIL | |
551 | AVP | arginine vasopressin (neurophysin II, antidiuretic hormone, diabetes insipidus, neurohypophyseal) | 20p13 | AVP | |
552 | AVPR1A | arginine vasopressin receptor 1A | 12q14-q15 | AVPR1A | |
553 | AVPR1B | arginine vasopressin receptor 1B | 1q32 | AVPR1B | |
567 | B2M | beta-2-microglobulin | 15q21-q22.2 | B2M | |
23621 | BACE1 | beta-site APP-cleaving enzyme 1 | 11q23.2-q23.3 | BACE1 | |
573 | BAG1 | BCL2-associated athanogene | 9p12 | BAG1 | |
9532 | BAG2 | BCL2-associated athanogene 2 | 6p12.3-p11.2 | BAG2 | |
7919 | BAT1 | HLA-B associated transcript 1 | 6p21.3 | BAT1 | |
7916 | BAT2 | HLA-B associated transcript 2 | 6p21.3 | BAT2 | |
581 | BAX | BCL2-associated X protein | 19q13.3-q13.4 | BAX | |
590 | BCHE | butyrylcholinesterase | 3q26.1-q26.2 | BCHE | |
8915 | BCL10 | B-cell CLL/lymphoma 10 | 1p22 | BCL10 | |
596 | BCL2 | B-cell CLL/lymphoma 2 | 18q21.33|18q21.3 | BCL2 | |
602 | BCL3 | B-cell CLL/lymphoma 3 | 19q13.1-q13.2 | BCL3 | |
613 | BCR | breakpoint cluster region | 22q11|22q11.23 | BCR | |
624 | BDKRB2 | bradykinin receptor B2 | 14q32.1-q32.2 | BDKRB2 | |
627 | BDNF | brain-derived neurotrophic factor | 11p13 | BDNF | |
633 | BGN | biglycan | Xq28 | BGN | |
635 | BHMT | betaine-homocysteine methyltransferase | 5q13.1-q15 | BHMT | |
637 | BID | BH3 interacting domain death agonist | 22q11.1 | BID | |
638 | BIK | BCL2-interacting killer (apoptosis-inducing) | 22q13.31 | BIK | |
641 | BLM | Bloom syndrome | 15q26.1 | BLM | |
648 | BMI1 | BMI1 polycomb ring finger oncogene | 10p11.23 | BMI1 | |
9210 | BMP15 | bone morphogenetic protein 15 | Xp11.2 | BMP15 | |
650 | BMP2 | bone morphogenetic protein 2 | 20p12 | BMP2 | |
651 | BMP3 | bone morphogenetic protein 3 | 4q21 | BMP3 | |
652 | BMP4 | bone morphogenetic protein 4 | 14q22-q23 | BMP4 | |
658 | BMPR1B | bone morphogenetic protein receptor, type IB | 4q22-q24 | BMPR1B | |
91653 | BOC | Boc homolog (mouse) | 3q13.2 | BOC | |
666 | BOK | BCL2-related ovarian killer | 2q37.3 | BOK | |
66037 | BOLL | bol, boule-like (Drosophila) | 2q33 | BOLL | |
100131534 | BPA-1 | - | 1p31.3 | BPA-1 | |
670 | BPHL | biphenyl hydrolase-like (serine hydrolase; breast epithelial mucin-associated antigen) | 6p25 | BPHL | |
671 | BPI | bactericidal/permeability-increasing protein | 20q11.23-q12 | BPI | |
673 | BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 7q34 | BRAF | |
672 | BRCA1 | breast cancer 1, early onset | 17q21 | BRCA1 | |
675 | BRCA2 | breast cancer 2, early onset | 13q12.3 | BRCA2 | |
682 | BSG | basigin (Ok blood group) | 19p13.3 | BSG | |
8927 | BSN | bassoon (presynaptic cytomatrix protein) | 3p21.31 | BSN | |
685 | BTC | betacellulin | 4q13-q21 | BTC | |
686 | BTD | biotinidase | 3p25 | BTD | |
695 | BTK | Bruton agammaglobulinemia tyrosine kinase | Xq21.33-q22 | BTK | |
151888 | BTLA | B and T lymphocyte associated | 3q13.2 | BTLA | |
712 | C1QA | complement component 1, q subcomponent, A chain | 1p36.12 | C1QA | |
713 | C1QB | complement component 1, q subcomponent, B chain | 1p36.12 | C1QB | |
716 | C1S | complement component 1, s subcomponent | 12p13 | C1S | |
720 | C4A | complement component 4A (Rodgers blood group) | 6p21.3 | C4A | |
759 | CA1 | carbonic anhydrase I | 8q13-q22.1 | CA1 | |
56934 | CA10 | carbonic anhydrase X | 17q21.33 | CA10 | |
760 | CA2 | carbonic anhydrase II | 8q22 | CA2 | |
761 | CA3 | carbonic anhydrase III, muscle specific | 8q13-q22 | CA3 | |
762 | CA4 | carbonic anhydrase IV | 17q23 | CA4 | |
773 | CACNA1A | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 19p13.2-p13.1 | CACNA1A | |
781 | CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 7q21-q22 | CACNA2D1 | |
796 | CALCA | calcitonin-related polypeptide alpha | 11p15.2-p15.1 | CALCA | |
813 | CALU | calumenin | 7q32 | CALU | |
10487 | CAP1 | CAP, adenylate cyclase-associated protein 1 (yeast) | 1p34.2 | CAP1 | |
828 | CAPS | calcyphosine | 19p13.3 | CAPS | |
64170 | CARD9 | caspase recruitment domain family, member 9 | 9q34.3 | CARD9 | |
10498 | CARM1 | coactivator-associated arginine methyltransferase 1 | 19p13.2 | CARM1 | |
833 | CARS | cysteinyl-tRNA synthetase | 11p15.5 | CARS | |
8573 | CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Xp11.4 | CASK | |
846 | CASR | calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) | 3q13 | CASR | |
831 | CAST | calpastatin | 5q15 | CAST | |
847 | CAT | catalase | 11p13 | CAT | |
857 | CAV1 | caveolin 1, caveolae protein, 22kDa | 7q31.1 | CAV1 | |
858 | CAV2 | caveolin 2 | 7q31.1 | CAV2 | |
859 | CAV3 | caveolin 3 | 3p25 | CAV3 | |
867 | CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 11q23.3 | CBL | |
873 | CBR1 | carbonyl reductase 1 | 21q22.13 | CBR1 | |
874 | CBR3 | carbonyl reductase 3 | 21q22.2 | CBR3 | |
84869 | CBR4 | carbonyl reductase 4 | 4q32.3 | CBR4 | |
875 | CBS | cystathionine-beta-synthase | 21q22.3 | CBS | |
885 | CCK | cholecystokinin | 3p22-p21.3 | CCK | |
886 | CCKAR | cholecystokinin A receptor | 4p15.1-p15.2 | CCKAR | |
887 | CCKBR | cholecystokinin B receptor | 11p15.4 | CCKBR | |
6346 | CCL1 | chemokine (C-C motif) ligand 1 | 17q12 | CCL1 | |
6361 | CCL17 | chemokine (C-C motif) ligand 17 | 16q13 | CCL17 | |
6347 | CCL2 | chemokine (C-C motif) ligand 2 | 17q11.2-q12 | CCL2 | |
6348 | CCL3 | chemokine (C-C motif) ligand 3 | 17q11-q21 | CCL3 | |
6352 | CCL5 | chemokine (C-C motif) ligand 5 | 17q11.2-q12 | CCL5 | |
595 | CCND1 | cyclin D1 | 11q13 | CCND1 | |
899 | CCNF | cyclin F | 16p13.3 | CCNF | |
1230 | CCR1 | chemokine (C-C motif) receptor 1 | 3p21 | CCR1 | |
1231 | CCR2 | chemokine (C-C motif) receptor 2 | 3p21.31 | CCR2 | |
1232 | CCR3 | chemokine (C-C motif) receptor 3 | 3p21.3 | CCR3 | |
1233 | CCR4 | chemokine (C-C motif) receptor 4 | 3p24 | CCR4 | |
1234 | CCR5 | chemokine (C-C motif) receptor 5 | 3p21.31 | CCR5 | |
1236 | CCR7 | chemokine (C-C motif) receptor 7 | 17q12-q21.2 | CCR7 | |
1237 | CCR8 | chemokine (C-C motif) receptor 8 | 3p22 | CCR8 | |
9973 | CCS | copper chaperone for superoxide dismutase | 11q13 | CCS | |
929 | CD14 | CD14 molecule | 5q22-q32|5q31.1 | CD14 | |
930 | CD19 | CD19 molecule | 16p11.2 | CD19 | |
909 | CD1A | CD1a molecule | 1q22-q23 | CD1A | |
914 | CD2 | CD2 molecule | 1p13 | CD2 | |
30835 | CD209 | CD209 molecule | 19p13 | CD209 | |
933 | CD22 | CD22 molecule | 19q13.1 | CD22 | |
939 | CD27 | CD27 molecule | 12p13 | CD27 | |
29126 | CD274 | CD274 molecule | 9p24 | CD274 | |
940 | CD28 | CD28 molecule | 2q33 | CD28 | |
945 | CD33 | CD33 molecule | 19q13.3 | CD33 | |
947 | CD34 | CD34 molecule | 1q32 | CD34 | |
948 | CD36 | CD36 molecule (thrombospondin receptor) | 7q11.2 | CD36 | |
952 | CD38 | CD38 molecule | 4p15 | CD38 | |
920 | CD4 | CD4 molecule | 12pter-p12 | CD4 | |
958 | CD40 | CD40 molecule, TNF receptor superfamily member 5 | 20q12-q13.2 | CD40 | |
960 | CD44 | CD44 molecule (Indian blood group) | 11p13 | CD44 | |
921 | CD5 | CD5 molecule | 11q13 | CD5 | |
1604 | CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 1q32 | CD55 | |
966 | CD59 | CD59 molecule, complement regulatory protein | 11p13 | CD59 | |
923 | CD6 | CD6 molecule | 11q13 | CD6 | |
967 | CD63 | CD63 molecule | 12q12-q13 | CD63 | |
968 | CD68 | CD68 molecule | 17p13 | CD68 | |
969 | CD69 | CD69 molecule | 12p13-p12 | CD69 | |
924 | CD7 | CD7 molecule | 17q25.2-q25.3 | CD7 | |
941 | CD80 | CD80 molecule | 3q13.3-q21 | CD80 | |
975 | CD81 | CD81 molecule | 11p15.5 | CD81 | |
942 | CD86 | CD86 molecule | 3q21 | CD86 | |
925 | CD8A | CD8a molecule | 2p12 | CD8A | |
4267 | CD99 | CD99 molecule | Xp22.32; Yp11.3 | CD99 | |
978 | CDA | cytidine deaminase | 1p36.2-p35 | CDA | |
983 | CDC2 | cell division cycle 2, G1 to S and G2 to M | 10q21.1 | CDC2 | |
998 | CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 1p36.1 | CDC42 | |
8317 | CDC7 | cell division cycle 7 homolog (S. cerevisiae) | 1p22 | CDC7 | |
999 | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 16q22.1 | CDH1 | |
1017 | CDK2 | cyclin-dependent kinase 2 | 12q13 | CDK2 | |
1019 | CDK4 | cyclin-dependent kinase 4 | 12q14 | CDK4 | |
1020 | CDK5 | cyclin-dependent kinase 5 | 7q36 | CDK5 | |
1021 | CDK6 | cyclin-dependent kinase 6 | 7q21-q22 | CDK6 | |
1029 | CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 9p21 | CDKN2A | |
1038 | CDR1 | cerebellar degeneration-related protein 1, 34kDa | Xq27.1-q27.2 | CDR1 | |
1039 | CDR2 | cerebellar degeneration-related protein 2, 62kDa | 16p12.3 | CDR2 | |
1056 | CEL | carboxyl ester lipase (bile salt-stimulated lipase) | 9q34.3 | CEL | |
10390 | CEPT1 | choline/ethanolamine phosphotransferase 1 | 1p13.3 | CEPT1 | |
9350 | CER1 | cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis) | 9p23-p22 | CER1 | |
1066 | CES1 | carboxylesterase 1 (monocyte/macrophage serine esterase 1) | 16q13-q22.1 | CES1 | |
8824 | CES2 | carboxylesterase 2 (intestine, liver) | 16q22.1 | CES2 | |
23491 | CES3 | carboxylesterase 3 (brain) | 16q22.1 | CES3 | |
1071 | CETP | cholesteryl ester transfer protein, plasma | 16q21 | CETP | |
629 | CFB | complement factor B | 6p21.3 | CFB | |
55997 | CFC1 | cripto, FRL-1, cryptic family 1 | 2q21.1 | CFC1 | |
1675 | CFD | complement factor D (adipsin) | 19p13.3 | CFD | |
3426 | CFI | complement factor I | 4q25 | CFI | |
5199 | CFP | complement factor properdin | Xp11.3-p11.23 | CFP | |
1080 | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 7q31.2 | CFTR | |
1081 | CGA | glycoprotein hormones, alpha polypeptide | 6q12-q21 | CGA | |
1082 | CGB | chorionic gonadotropin, beta polypeptide | 19q13.32 | CGB | |
57530 | CGN | cingulin | 1q21 | CGN | |
1103 | CHAT | choline acetyltransferase | 10q11.2 | CHAT | |
1105 | CHD1 | chromodomain helicase DNA binding protein 1 | 5q15-q21 | CHD1 | |
1106 | CHD2 | chromodomain helicase DNA binding protein 2 | 15q26 | CHD2 | |
1110 | CHE2 | cholinesterase (serum) 2 | 2q33-q35 | CHE2 | |
11200 | CHEK2 | CHK2 checkpoint homolog (S. pombe) | 22q11|22q12.1 | CHEK2 | |
27159 | CHIA | chitinase, acidic | 1p13.1-p21.3 | CHIA | |
1121 | CHM | choroideremia (Rab escort protein 1) | Xq21.2 | CHM | |
1124 | CHN2 | chimerin (chimaerin) 2 | 7p15.3 | CHN2 | |
11261 | CHP | - | 15q13.3 | CHP | |
1128 | CHRM1 | cholinergic receptor, muscarinic 1 | 11q13 | CHRM1 | |
1129 | CHRM2 | cholinergic receptor, muscarinic 2 | 7q31-q35 | CHRM2 | |
1133 | CHRM5 | cholinergic receptor, muscarinic 5 | 15q26 | CHRM5 | |
1134 | CHRNA1 | cholinergic receptor, nicotinic, alpha 1 (muscle) | 2q24-q32 | CHRNA1 | |
57053 | CHRNA10 | cholinergic receptor, nicotinic, alpha 10 | 11p15.5 | CHRNA10 | |
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | 8p21 | CHRNA2 | |
1136 | CHRNA3 | cholinergic receptor, nicotinic, alpha 3 | 15q24 | CHRNA3 | |
1137 | CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 20q13.2-q13.3 | CHRNA4 | |
1138 | CHRNA5 | cholinergic receptor, nicotinic, alpha 5 | 15q24 | CHRNA5 | |
8973 | CHRNA6 | cholinergic receptor, nicotinic, alpha 6 | 8p11.21 | CHRNA6 | |
1139 | CHRNA7 | cholinergic receptor, nicotinic, alpha 7 | 15q14 | CHRNA7 | |
55584 | CHRNA9 | cholinergic receptor, nicotinic, alpha 9 | 4p14 | CHRNA9 | |
1140 | CHRNB1 | cholinergic receptor, nicotinic, beta 1 (muscle) | 17p13.1 | CHRNB1 | |
1141 | CHRNB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 1q21.3 | CHRNB2 | |
1142 | CHRNB3 | cholinergic receptor, nicotinic, beta 3 | 8p11.2 | CHRNB3 | |
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 | 15q24 | CHRNB4 | |
23152 | CIC | capicua homolog (Drosophila) | 19q13.2 | CIC | |
63924 | CIDEC | cell death-inducing DFFA-like effector c | 3p25.3 | CIDEC | |
9541 | CIR | - | 2q31.1 | CIR | |
1154 | CISH | cytokine inducible SH2-containing protein | 3p21.3 | CISH | |
11113 | CIT | citron (rho-interacting, serine/threonine kinase 21) | 12q24 | CIT | |
10370 | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 6q23.3 | CITED2 | |
1158 | CKM | creatine kinase, muscle | 19q13.2-q13.3 | CKM | |
1178 | CLC | Charcot-Leyden crystal protein | 19q13.1 | CLC | |
1184 | CLCN5 | chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) | Xp11.23-p11.22 | CLCN5 | |
1201 | CLN3 | ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) | 16p12.1 | CLN3 | |
9575 | CLOCK | clock homolog (mouse) | 4q12 | CLOCK | |
81570 | CLPB | ClpB caseinolytic peptidase B homolog (E. coli) | 11q13.4 | CLPB | |
8192 | CLPP | ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) | 19p13.3 | CLPP | |
1208 | CLPS | colipase, pancreatic | 6pter-p21.1 | CLPS | |
10845 | CLPX | ClpX caseinolytic peptidase X homolog (E. coli) | 15q22.2-q22.3 | CLPX | |
1191 | CLU | clusterin | 8p21-p12 | CLU | |
1215 | CMA1 | chymase 1, mast cell | 14q11.2 | CMA1 | |
55907 | CMAS | cytidine monophosphate N-acetylneuraminic acid synthetase | 12p12.1 | CMAS | |
7555 | CNBP | CCHC-type zinc finger, nucleic acid binding protein | 3q21 | CNBP | |
55330 | CNO | cappuccino homolog (mouse) | 4p16.1 | CNO | |
1267 | CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | 17q21 | CNP | |
1268 | CNR1 | cannabinoid receptor 1 (brain) | 6q14-q15 | CNR1 | |
1270 | CNTF | ciliary neurotrophic factor | 11q12.2 | CNTF | |
25920 | COBRA1 | cofactor of BRCA1 | 9q34 | COBRA1 | |
1690 | COCH | coagulation factor C homolog, cochlin (Limulus polyphemus) | 14q12-q13 | COCH | |
1277 | COL1A1 | collagen, type I, alpha 1 | 17q21.33 | COL1A1 | |
1278 | COL1A2 | collagen, type I, alpha 2 | 7q22.1 | COL1A2 | |
1281 | COL3A1 | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | 2q31 | COL3A1 | |
1311 | COMP | cartilage oligomeric matrix protein | 19p13.1 | COMP | |
1312 | COMT | catechol-O-methyltransferase | 22q11.21-q11.23|22q11.21 | COMT | |
1313 | COP | clathrin-ordered protein | - | COP | |
1314 | COPA | coatomer protein complex, subunit alpha | 1q23-q25 | COPA | |
10229 | COQ7 | coenzyme Q7 homolog, ubiquinone (yeast) | 16p13.11-p12.3 | COQ7 | |
57017 | COQ9 | coenzyme Q9 homolog (S. cerevisiae) | 16q13 | COQ9 | |
1325 | CORT | cortistatin | 1p36|1p36.22 | CORT | |
4512 | COX1 | mitochondrially encoded cytochrome c oxidase I | - | COX1 | |
4513 | COX2 | mitochondrially encoded cytochrome c oxidase II | - | COX2 | |
4514 | COX3 | mitochondrially encoded cytochrome c oxidase III | - | COX3 | |
9377 | COX5A | cytochrome c oxidase subunit Va | 15q25 | COX5A | |
1356 | CP | ceruloplasmin (ferroxidase) | 3q23-q25 | CP | |
1357 | CPA1 | carboxypeptidase A1 (pancreatic) | 7q32 | CPA1 | |
1362 | CPD | carboxypeptidase D | 17q11.2 | CPD | |
1363 | CPE | carboxypeptidase E | 4q32.3 | CPE | |
1368 | CPM | carboxypeptidase M | 12q14.3 | CPM | |
130749 | CPO | carboxypeptidase O | 2q33.3 | CPO | |
1373 | CPS1 | carbamoyl-phosphate synthetase 1, mitochondrial | 2q35 | CPS1 | |
1374 | CPT1A | carnitine palmitoyltransferase 1A (liver) | 11q13.1-q13.2 | CPT1A | |
8532 | CPZ | carboxypeptidase Z | 4p16.1 | CPZ | |
1378 | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 1q32 | CR1 | |
1380 | CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 1q32 | CR2 | |
1381 | CRABP1 | cellular retinoic acid binding protein 1 | 15q24 | CRABP1 | |
1382 | CRABP2 | cellular retinoic acid binding protein 2 | 1q21.3 | CRABP2 | |
1385 | CREB1 | cAMP responsive element binding protein 1 | 2q34 | CREB1 | |
1390 | CREM | cAMP responsive element modulator | 10p11.21 | CREM | |
1392 | CRH | corticotropin releasing hormone | 8q13 | CRH | |
1394 | CRHR1 | corticotropin releasing hormone receptor 1 | 17q12-q22 | CRHR1 | |
1395 | CRHR2 | corticotropin releasing hormone receptor 2 | 7p15.1 | CRHR2 | |
1398 | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 17p13.3 | CRK | |
51747 | CROP | - | 17q21.33 | CROP | |
1401 | CRP | C-reactive protein, pentraxin-related | 1q21-q23 | CRP | |
1406 | CRX | cone-rod homeobox | 19q13.3 | CRX | |
1407 | CRY1 | cryptochrome 1 (photolyase-like) | 12q23-q24.1 | CRY1 | |
1408 | CRY2 | cryptochrome 2 (photolyase-like) | 11p11.2 | CRY2 | |
1410 | CRYAB | crystallin, alpha B | 11q22.3-q23.1 | CRYAB | |
1431 | CS | citrate synthase | 12q13.2-q13.3 | CS | |
1435 | CSF1 | colony stimulating factor 1 (macrophage) | 1p21-p13 | CSF1 | |
1440 | CSF3 | colony stimulating factor 3 (granulocyte) | 17q11.2-q12 | CSF3 | |
1445 | CSK | c-src tyrosine kinase | 15q23-q25 | CSK | |
1489 | CTF1 | cardiotrophin 1 | 16p11.2-p11.1 | CTF1 | |
1490 | CTGF | connective tissue growth factor | 6q23.1 | CTGF | |
1491 | CTH | cystathionase (cystathionine gamma-lyase) | 1p31.1 | CTH | |
1499 | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 3p21 | CTNNB1 | |
1506 | CTRL | chymotrypsin-like | 16q22.1 | CTRL | |
1510 | CTSE | cathepsin E | 1q31 | CTSE | |
23316 | CUX2 | cut-like homeobox 2 | 12q24.11-q24.12 | CUX2 | |
2919 | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 4q21 | CXCL1 | |
3627 | CXCL10 | chemokine (C-X-C motif) ligand 10 | 4q21 | CXCL10 | |
6373 | CXCL11 | chemokine (C-X-C motif) ligand 11 | 4q21.2 | CXCL11 | |
2920 | CXCL2 | chemokine (C-X-C motif) ligand 2 | 4q21 | CXCL2 | |
4283 | CXCL9 | chemokine (C-X-C motif) ligand 9 | 4q21 | CXCL9 | |
2833 | CXCR3 | chemokine (C-X-C motif) receptor 3 | Xq13 | CXCR3 | |
7852 | CXCR4 | chemokine (C-X-C motif) receptor 4 | 2q21 | CXCR4 | |
1537 | CYC1 | cytochrome c-1 | 8q24.3 | CYC1 | |
1585 | CYP11B2 | cytochrome P450, family 11, subfamily B, polypeptide 2 | 8q21-q22 | CYP11B2 | |
1586 | CYP17A1 | cytochrome P450, family 17, subfamily A, polypeptide 1 | 10q24.3 | CYP17A1 | |
1543 | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 15q22-q24 | CYP1A1 | |
1544 | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 15q24 | CYP1A2 | |
1545 | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 2p21 | CYP1B1 | |
1591 | CYP24A1 | cytochrome P450, family 24, subfamily A, polypeptide 1 | 20q13 | CYP24A1 | |
1592 | CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 10q23-q24 | CYP26A1 | |
1593 | CYP27A1 | cytochrome P450, family 27, subfamily A, polypeptide 1 | 2q33-qter | CYP27A1 | |
1594 | CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 | 12q13.1-q13.3 | CYP27B1 | |
1553 | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 | 19q13.2 | CYP2A13 | |
1548 | CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 19q13.2 | CYP2A6 | |
1555 | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 19q13.2 | CYP2B6 | |
1562 | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 10q24 | CYP2C18 | |
1557 | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 10q24.1-q24.3 | CYP2C19 | |
1558 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 10q23.33 | CYP2C8 | |
1559 | CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 10q24 | CYP2C9 | |
1565 | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 22q13.1 | CYP2D6 | |
1571 | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 10q24.3-qter | CYP2E1 | |
1572 | CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 | 19q13.2 | CYP2F1 | |
1573 | CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 1p31.3-p31.2 | CYP2J2 | |
1576 | CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 7q21.1 | CYP3A4 | |
1577 | CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 7q21.1 | CYP3A5 | |
1551 | CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 7q21-q22.1 | CYP3A7 | |
1579 | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 1p33 | CYP4A11 | |
1580 | CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 1p34-p12 | CYP4B1 | |
8529 | CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 19pter-p13.11 | CYP4F2 | |
1581 | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 | 8q11-q12 | CYP7A1 | |
1582 | CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 3p22-p21.3 | CYP8B1 | |
192668 | CYS1 | cystin 1 | 2p25.1 | CYS1 | |
4519 | CYTB | mitochondrially encoded cytochrome b | - | CYTB | |
26007 | DAK | dihydroxyacetone kinase 2 homolog (S. cerevisiae) | 11q12.2 | DAK | |
1610 | DAO | D-amino-acid oxidase | 12q24 | DAO | |
1611 | DAP | death-associated protein | 5p15.2 | DAP | |
27071 | DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 4q25-q27 | DAPP1 | |
2532 | DARC | Duffy blood group, chemokine receptor | 1q21-q22 | DARC | |
1618 | DAZL | deleted in azoospermia-like | 3p24.3 | DAZL | |
1621 | DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 9q34 | DBH | |
1622 | DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) | 2q12-q21 | DBI | |
1629 | DBT | dihydrolipoamide branched chain transacylase E2 | 1p31 | DBT | |
1630 | DCC | deleted in colorectal carcinoma | 18q21.3 | DCC | |
117159 | DCD | dermcidin | 12q13.1 | DCD | |
1632 | DCI | dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase) | 16p13.3 | DCI | |
1633 | DCK | deoxycytidine kinase | 4q13.3-q21.1 | DCK | |
1634 | DCN | decorin | 12q21.33 | DCN | |
28960 | DCPS | decapping enzyme, scavenger | 11q24.2 | DCPS | |
1638 | DCT | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) | 13q32 | DCT | |
1641 | DCX | doublecortex; lissencephaly, X-linked (doublecortin) | Xq22.3-q23 | DCX | |
1644 | DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 7p11 | DDC | |
23109 | DDN | dendrin | 12q13.12 | DDN | |
8528 | DDO | D-aspartate oxidase | 6q21 | DDO | |
1652 | DDT | D-dopachrome tautomerase | 22q11.23 | DDT | |
1655 | DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 17q21 | DDX5 | |
50514 | DEC1 | deleted in esophageal cancer 1 | 9q32 | DEC1 | |
1674 | DES | desmin | 2q35 | DES | |
8694 | DGAT1 | diacylglycerol O-acyltransferase homolog 1 (mouse) | 8q24.3 | DGAT1 | |
84649 | DGAT2 | diacylglycerol O-acyltransferase homolog 2 (mouse) | 11q13.5 | DGAT2 | |
1717 | DHCR7 | 7-dehydrocholesterol reductase | 11q13.2-q13.5 | DHCR7 | |
1719 | DHFR | dihydrofolate reductase | 5q11.2-q13.2 | DHFR | |
1725 | DHPS | deoxyhypusine synthase | 19p13.2-p13.1 | DHPS | |
10901 | DHRS4 | dehydrogenase/reductase (SDR family) member 4 | 14q11.2 | DHRS4 | |
10170 | DHRS9 | dehydrogenase/reductase (SDR family) member 9 | 2q31.1 | DHRS9 | |
56616 | DIABLO | diablo homolog (Drosophila) | 12q24.31 | DIABLO | |
27185 | DISC1 | disrupted in schizophrenia 1 | 1q42.1 | DISC1 | |
1737 | DLAT | dihydrolipoamide S-acetyltransferase | 11q23.1 | DLAT | |
1738 | DLD | dihydrolipoamide dehydrogenase | 7q31-q32 | DLD | |
9231 | DLG5 | discs, large homolog 5 (Drosophila) | 10q23 | DLG5 | |
8788 | DLK1 | delta-like 1 homolog (Drosophila) | 14q32 | DLK1 | |
11144 | DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 22q13.1 | DMC1 | |
1756 | DMD | dystrophin (muscular dystrophy, Duchenne and Becker types) | Xp21.2 | DMD | |
23336 | DMN | desmuslin | 15q26.3 | DMN | |
1760 | DMPK | dystrophia myotonica-protein kinase | 19q13.3 | DMPK | |
1789 | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 20q11.2 | DNMT3B | |
1803 | DPP4 | dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) | 2q24.3 | DPP4 | |
1805 | DPT | dermatopontin | 1q12-q23 | DPT | |
55332 | DRAM | - | 12q23.2 | DRAM | |
1812 | DRD1 | dopamine receptor D1 | 5q35.1 | DRD1 | |
1813 | DRD2 | dopamine receptor D2 | 11q23 | DRD2 | |
1814 | DRD3 | dopamine receptor D3 | 3q13.3 | DRD3 | |
1815 | DRD4 | dopamine receptor D4 | 11p15.5 | DRD4 | |
1816 | DRD5 | dopamine receptor D5 | 4p16.1 | DRD5 | |
29940 | DSE | dermatan sulfate epimerase | 6q22 | DSE | |
1832 | DSP | desmoplakin | 6p24 | DSP | |
667 | DST | dystonin | 6p12.1 | DST | |
51514 | DTL | denticleless homolog (Drosophila) | 1q32.1-q32.2 | DTL | |
1837 | DTNA | dystrobrevin, alpha | 18q12 | DTNA | |
1838 | DTNB | dystrobrevin, beta | 2p24 | DTNB | |
1850 | DUSP8 | dual specificity phosphatase 8 | 11p15.5 | DUSP8 | |
1869 | E2F1 | E2F transcription factor 1 | 20q11.2 | E2F1 | |
1874 | E2F4 | E2F transcription factor 4, p107/p130-binding | 16q21-q22 | E2F4 | |
55837 | EAPP | E2F-associated phosphoprotein | 14q13.1 | EAPP | |
10682 | EBP | emopamil binding protein (sterol isomerase) | Xp11.23-p11.22 | EBP | |
11319 | ECD | ecdysoneless homolog (Drosophila) | 10q22.1 | ECD | |
1896 | EDA | ectodysplasin A | Xq12-q13.1 | EDA | |
1906 | EDN1 | endothelin 1 | 6p24.1 | EDN1 | |
1917 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | 20q13.3 | EEF1A2 | |
1938 | EEF2 | eukaryotic translation elongation factor 2 | 19pter-q12 | EEF2 | |
29904 | EEF2K | eukaryotic elongation factor-2 kinase | 16p12.1 | EEF2K | |
10278 | EFS | embryonal Fyn-associated substrate | 14q11.2-q12 | EFS | |
1950 | EGF | epidermal growth factor (beta-urogastrone) | 4q25 | EGF | |
1956 | EGFR | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 7p12 | EGFR | |
1958 | EGR1 | early growth response 1 | 5q31.1 | EGR1 | |
1977 | EIF4E | eukaryotic translation initiation factor 4E | 4q21-q25 | EIF4E | |
1984 | EIF5A | eukaryotic translation initiation factor 5A | 17p13-p12 | EIF5A | |
1993 | ELAVL2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) | 9p21 | ELAVL2 | |
2002 | ELK1 | ELK1, member of ETS oncogene family | Xp11.2 | ELK1 | |
8178 | ELL | elongation factor RNA polymerase II | 19p13.1 | ELL | |
2006 | ELN | elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) | 7q11.23 | ELN | |
133418 | EMB | embigin homolog (mouse) | 5q11.1 | EMB | |
2010 | EMD | emerin (Emery-Dreifuss muscular dystrophy) | Xq28 | EMD | |
2018 | EMX2 | empty spiracles homeobox 2 | 10q26.1 | EMX2 | |
2020 | EN2 | engrailed homeobox 2 | 7q36 | EN2 | |
2022 | ENG | endoglin (Osler-Rendu-Weber syndrome 1) | 9q33-q34.1 | ENG | |
2023 | ENO1 | enolase 1, (alpha) | 1p36.3-p36.2 | ENO1 | |
2026 | ENO2 | enolase 2 (gamma, neuronal) | 12p13 | ENO2 | |
2050 | EPHB4 | EPH receptor B4 | 7q22 | EPHB4 | |
2052 | EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 1q42.1 | EPHX1 | |
2053 | EPHX2 | epoxide hydrolase 2, cytoplasmic | 8p21-p12 | EPHX2 | |
2056 | EPO | erythropoietin | 7q22 | EPO | |
2058 | EPRS | glutamyl-prolyl-tRNA synthetase | 1q41-q42 | EPRS | |
2059 | EPS8 | epidermal growth factor receptor pathway substrate 8 | 12q13 | EPS8 | |
3266 | ERAS | ES cell expressed Ras | Xp11.23 | ERAS | |
2064 | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 17q11.2-q12|17q21.1 | ERBB2 | |
2065 | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 12q13 | ERBB3 | |
2066 | ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 2q33.3-q34 | ERBB4 | |
2067 | ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | 19q13.2-q13.3 | ERCC1 | |
2068 | ERCC2 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) | 19q13.3 | ERCC2 | |
2071 | ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 2q21 | ERCC3 | |
2072 | ERCC4 | excision repair cross-complementing rodent repair deficiency, complementation group 4 | 16p13.3-p13.11 | ERCC4 | |
2073 | ERCC5 | excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | 13q22|13q33 | ERCC5 | |
2074 | ERCC6 | excision repair cross-complementing rodent repair deficiency, complementation group 6 | 10q11.23 | ERCC6 | |
54821 | ERCC6L | excision repair cross-complementing rodent repair deficiency, complementation group 6-like | Xq13.1 | ERCC6L | |
2077 | ERF | Ets2 repressor factor | 19q13 | ERF | |
2078 | ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 21q22.3 | ERG | |
2079 | ERH | enhancer of rudimentary homolog (Drosophila) | 14q24.1|7q34 | ERH | |
2098 | ESD | esterase D/formylglutathione hydrolase | 13q14.1-q14.2 | ESD | |
2099 | ESR1 | estrogen receptor 1 | 6q25.1 | ESR1 | |
51466 | EVL | Enah/Vasp-like | 14q32.2 | EVL | |
2159 | F10 | coagulation factor X | 13q34 | F10 | |
2160 | F11 | coagulation factor XI (plasma thromboplastin antecedent) | 4q35 | F11 | |
2161 | F12 | coagulation factor XII (Hageman factor) | 5q33-qter | F12 | |
2165 | F13B | coagulation factor XIII, B polypeptide | 1q31-q32.1 | F13B | |
2153 | F5 | coagulation factor V (proaccelerin, labile factor) | 1q23 | F5 | |
2155 | F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 13q34 | F7 | |
2157 | F8 | coagulation factor VIII, procoagulant component (hemophilia A) | Xq28 | F8 | |
2158 | F9 | coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B) | Xq27.1-q27.2 | F9 | |
2166 | FAAH | fatty acid amide hydrolase | 1p35-p34 | FAAH | |
2168 | FABP1 | fatty acid binding protein 1, liver | 2p11 | FABP1 | |
2169 | FABP2 | fatty acid binding protein 2, intestinal | 4q28-q31 | FABP2 | |
8772 | FADD | Fas (TNFRSF6)-associated via death domain | 11q13.3 | FADD | |
3992 | FADS1 | fatty acid desaturase 1 | 11q12.2-q13.1 | FADS1 | |
9415 | FADS2 | fatty acid desaturase 2 | 11q12-q13.1 | FADS2 | |
2184 | FAH | fumarylacetoacetate hydrolase (fumarylacetoacetase) | 15q23-q25 | FAH | |
2188 | FANCF | Fanconi anemia, complementation group F | 11p15 | FANCF | |
2191 | FAP | fibroblast activation protein, alpha | 2q23 | FAP | |
2194 | FASN | fatty acid synthase | 17q25 | FASN | |
2197 | FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | 11q13 | FAU | |
2091 | FBL | fibrillarin | 19q13.1 | FBL | |
10516 | FBLN5 | fibulin 5 | 14q32.1 | FBLN5 | |
2200 | FBN1 | fibrillin 1 | 15q21.1 | FBN1 | |
2203 | FBP1 | fructose-1,6-bisphosphatase 1 | 9q22.3 | FBP1 | |
8789 | FBP2 | fructose-1,6-bisphosphatase 2 | 9q22.3 | FBP2 | |
64319 | FBRS | fibrosin | 16p11.2 | FBRS | |
2224 | FDPS | farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase) | 1q22 | FDPS | |
2241 | FER | fer (fps/fes related) tyrosine kinase | 5q21 | FER | |
2242 | FES | feline sarcoma oncogene | 15q26.1 | FES | |
54738 | FEV | FEV (ETS oncogene family) | 2q36 | FEV | |
2244 | FGB | fibrinogen beta chain | 4q28 | FGB | |
2246 | FGF1 | fibroblast growth factor 1 (acidic) | 5q31 | FGF1 | |
2247 | FGF2 | fibroblast growth factor 2 (basic) | 4q26-q27 | FGF2 | |
2253 | FGF8 | fibroblast growth factor 8 (androgen-induced) | 10q24 | FGF8 | |
2260 | FGFR1 | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | 8p11.2-p11.1 | FGFR1 | |
2266 | FGG | fibrinogen gamma chain | 4q28 | FGG | |
2268 | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 1p36.2-p36.1 | FGR | |
2271 | FH | fumarate hydratase | 1q42.1 | FH | |
2272 | FHIT | fragile histidine triad gene | 3p14.2 | FHIT | |
2273 | FHL1 | four and a half LIM domains 1 | Xq26 | FHL1 | |
2277 | FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | Xp22.31 | FIGF | |
51024 | FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 7q22.1 | FIS1 | |
2313 | FLI1 | Friend leukemia virus integration 1 | 11q24.1-q24.3 | FLI1 | |
2324 | FLT4 | fms-related tyrosine kinase 4 | 5q35.3 | FLT4 | |
2326 | FMO1 | flavin containing monooxygenase 1 | 1q23-q25 | FMO1 | |
2327 | FMO2 | flavin containing monooxygenase 2 (non-functional) | 1q23-q25 | FMO2 | |
2328 | FMO3 | flavin containing monooxygenase 3 | 1q23-q25 | FMO3 | |
2332 | FMR1 | fragile X mental retardation 1 | Xq27.3 | FMR1 | |
2354 | FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 19q13.32 | FOSB | |
2308 | FOXO1 | forkhead box O1 | 13q14.1 | FOXO1 | |
2444 | FRK | fyn-related kinase | 6q21-q22.3 | FRK | |
10129 | FRY | furry homolog (Drosophila) | 13q13.1 | FRY | |
2487 | FRZB | frizzled-related protein | 2qter | FRZB | |
2492 | FSHR | follicle stimulating hormone receptor | 2p21-p16 | FSHR | |
10468 | FST | follistatin | 5q11.2 | FST | |
2512 | FTL | ferritin, light polypeptide | 19q13.3-q13.4 | FTL | |
2517 | FUCA1 | fucosidase, alpha-L- 1, tissue | 1p34 | FUCA1 | |
5045 | FURIN | furin (paired basic amino acid cleaving enzyme) | 15q26.1 | FURIN | |
2521 | FUS | fusion (involved in t(12;16) in malignant liposarcoma) | 16p11.2 | FUS | |
2525 | FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | 19p13.3 | FUT3 | |
53826 | FXYD6 | FXYD domain containing ion transport regulator 6 | 11q23.3 | FXYD6 | |
2534 | FYN | FYN oncogene related to SRC, FGR, YES | 6q21 | FYN | |
2538 | G6PC | glucose-6-phosphatase, catalytic subunit | 17q21 | G6PC | |
2539 | G6PD | glucose-6-phosphate dehydrogenase | Xq28 | G6PD | |
2548 | GAA | glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II) | 17q25.2-q25.3 | GAA | |
11337 | GABARAP | GABA(A) receptor-associated protein | 17p13.1 | GABARAP | |
2554 | GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 5q34-q35 | GABRA1 | |
2555 | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 | 4p12 | GABRA2 | |
2557 | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 | 4p12 | GABRA4 | |
2558 | GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | 15q11.2-q12 | GABRA5 | |
2559 | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 | 5q34 | GABRA6 | |
2560 | GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 | 4p12 | GABRB1 | |
2561 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 | 5q34 | GABRB2 | |
2562 | GABRB3 | gamma-aminobutyric acid (GABA) A receptor, beta 3 | 15q11.2-q12 | GABRB3 | |
2563 | GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 1p|1p36.3 | GABRD | |
2565 | GABRG1 | gamma-aminobutyric acid (GABA) A receptor, gamma 1 | 4p12 | GABRG1 | |
2566 | GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 5q31.1-q33.1 | GABRG2 | |
2567 | GABRG3 | gamma-aminobutyric acid (GABA) A receptor, gamma 3 | 15q12 | GABRG3 | |
2571 | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) | 2q31 | GAD1 | |
2572 | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 10p11.23 | GAD2 | |
653499 | GAL7 | - | 19q13.2 | GAL7 | |
2582 | GALE | UDP-galactose-4-epimerase | 1p36-p35 | GALE | |
51809 | GALNT7 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) | 4q31.1 | GALNT7 | |
85569 | GALP | galanin-like peptide | 19q13.42 | GALP | |
2587 | GALR1 | galanin receptor 1 | 18q23 | GALR1 | |
8811 | GALR2 | galanin receptor 2 | 17q25.3 | GALR2 | |
8484 | GALR3 | galanin receptor 3 | 22q13.1 | GALR3 | |
2592 | GALT | galactose-1-phosphate uridylyltransferase | 9p13 | GALT | |
8139 | GAN | giant axonal neuropathy (gigaxonin) | 16q24.1 | GAN | |
2596 | GAP43 | growth associated protein 43 | 3q13.1-q13.2 | GAP43 | |
2597 | GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 12p13 | GAPDH | |
2619 | GAS1 | growth arrest-specific 1 | 9q21.3-q22 | GAS1 | |
2625 | GATA3 | GATA binding protein 3 | 10p15 | GATA3 | |
2626 | GATA4 | GATA binding protein 4 | 8p23.1-p22 | GATA4 | |
2627 | GATA6 | GATA binding protein 6 | 18q11.1-q11.2 | GATA6 | |
8729 | GBF1 | golgi-specific brefeldin A resistance factor 1 | 10q24 | GBF1 | |
64223 | GBL | - | 16p13.3 | GBL | |
2638 | GC | group-specific component (vitamin D binding protein) | 4q12-q13 | GC | |
25801 | GCA | grancalcin, EF-hand calcium binding protein | 2q24.2 | GCA | |
2641 | GCG | glucagon | 2q36-q37 | GCG | |
2643 | GCH1 | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 14q22.1-q22.2 | GCH1 | |
2729 | GCLC | glutamate-cysteine ligase, catalytic subunit | 6p12 | GCLC | |
2730 | GCLM | glutamate-cysteine ligase, modifier subunit | 1p22.1 | GCLM | |
9615 | GDA | guanine deaminase | 9q21.13 | GDA | |
51573 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 16p12-p11.2 | GDE1 | |
8200 | GDF5 | growth differentiation factor 5 | 20q11.2 | GDF5 | |
2668 | GDNF | glial cell derived neurotrophic factor | 5p13.1-p12 | GDNF | |
81544 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | 11q13.4-q13.5 | GDPD5 | |
115557 | GEFT | - | 12q13.3 | GEFT | |
2669 | GEM | GTP binding protein overexpressed in skeletal muscle | 8q13-q21 | GEM | |
2670 | GFAP | glial fibrillary acidic protein | 17q21 | GFAP | |
2688 | GH1 | growth hormone 1 | 17q24.2 | GH1 | |
2689 | GH2 | growth hormone 2 | 17q24.2 | GH2 | |
2690 | GHR | growth hormone receptor | 5p13-p12 | GHR | |
2691 | GHRH | growth hormone releasing hormone | 20q11.2 | GHRH | |
2694 | GIF | gastric intrinsic factor (vitamin B synthesis) | 11q13 | GIF | |
2695 | GIP | gastric inhibitory polypeptide | 17q21.3-q22 | GIP | |
28964 | GIT1 | G protein-coupled receptor kinase interactor 1 | 17p11.2 | GIT1 | |
2701 | GJA4 | gap junction protein, alpha 4, 37kDa | 1p35.1 | GJA4 | |
2710 | GK | glycerol kinase | Xp21.3 | GK | |
2717 | GLA | galactosidase, alpha | Xq22 | GLA | |
26035 | GLCE | glucuronic acid epimerase | 15q23 | GLCE | |
2735 | GLI1 | glioma-associated oncogene homolog 1 (zinc finger protein) | 12q13.2-q13.3 | GLI1 | |
2737 | GLI3 | GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome) | 7p13 | GLI3 | |
2739 | GLO1 | glyoxalase I | 6p21.3-p21.1 | GLO1 | |
100125288 | GLP-1 | - | 19p13.2 | GLP-1 | |
2741 | GLRA1 | glycine receptor, alpha 1 | 5q32 | GLRA1 | |
2742 | GLRA2 | glycine receptor, alpha 2 | Xp22.1-p21.3 | GLRA2 | |
2744 | GLS | glutaminase | 2q32-q34 | GLS | |
2752 | GLUL | glutamate-ammonia ligase (glutamine synthetase) | 1q31 | GLUL | |
2763 | GMFA | glia maturation factor, alpha | - | GMFA | |
2765 | GML | glycosylphosphatidylinositol anchored molecule like protein | 8q24.3 | GML | |
8833 | GMPS | guanine monphosphate synthetase | 3q24 | GMPS | |
2778 | GNAS | GNAS complex locus | 20q13.3 | GNAS | |
346562 | GNAT3 | guanine nucleotide binding protein, alpha transducing 3 | 7q21.11 | GNAT3 | |
2784 | GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 12p13 | GNB3 | |
10020 | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 9p13.3 | GNE | |
27232 | GNMT | glycine N-methyltransferase | 6p12 | GNMT | |
2799 | GNS | glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) | 12q14 | GNS | |
2813 | GP2 | glycoprotein 2 (zymogen granule membrane) | 16p12 | GP2 | |
2814 | GP5 | glycoprotein V (platelet) | 3q29 | GP5 | |
51206 | GP6 | glycoprotein VI (platelet) | 19q13.4 | GP6 | |
2816 | GPB | glycerol phosphatase, beta- | 8q | GPB | |
2817 | GPC1 | glypican 1 | 2q35-q37 | GPC1 | |
221914 | GPC2 | glypican 2 | 7q22.1 | GPC2 | |
2719 | GPC3 | glypican 3 | Xq26.1 | GPC3 | |
2819 | GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 12q12-q13 | GPD1 | |
2820 | GPD2 | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | 2q24.1 | GPD2 | |
2821 | GPI | glucose phosphate isomerase | 19q13.1 | GPI | |
2825 | GPR1 | G protein-coupled receptor 1 | 2q33.3 | GPR1 | |
338442 | GPR109A | G protein-coupled receptor 109A | 12q24.31 | GPR109A | |
2875 | GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 8q24.3 | GPT | |
2876 | GPX1 | glutathione peroxidase 1 | 3p21.3 | GPX1 | |
2878 | GPX3 | glutathione peroxidase 3 (plasma) | 5q23 | GPX3 | |
2880 | GPX5 | glutathione peroxidase 5 (epididymal androgen-related protein) | 6p22.1 | GPX5 | |
160622 | GRASP | GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein | 12q13.13 | GRASP | |
2885 | GRB2 | growth factor receptor-bound protein 2 | 17q24-q25 | GRB2 | |
2890 | GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 5q33|5q31.1 | GRIA1 | |
2898 | GRIK2 | glutamate receptor, ionotropic, kainate 2 | 6q16.3-q21 | GRIK2 | |
2899 | GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34-p33 | GRIK3 | |
2902 | GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 9q34.3 | GRIN1 | |
2904 | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 12p12 | GRIN2B | |
2905 | GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 17q25 | GRIN2C | |
2906 | GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 19q13.1-qter | GRIN2D | |
2917 | GRM7 | glutamate receptor, metabotropic 7 | 3p26.1-p25.1 | GRM7 | |
2896 | GRN | granulin | 17q21.32 | GRN | |
2922 | GRP | gastrin-releasing peptide | 18q21.1-q21.32 | GRP | |
2925 | GRPR | gastrin-releasing peptide receptor | Xp22.2-p22.13 | GRPR | |
145258 | GSC | goosecoid homeobox | 14q32.1 | GSC | |
2936 | GSR | glutathione reductase | 8p21.1 | GSR | |
2937 | GSS | glutathione synthetase | 20q11.2 | GSS | |
2938 | GSTA1 | glutathione S-transferase A1 | 6p12.1 | GSTA1 | |
2941 | GSTA4 | glutathione S-transferase A4 | 6p12.1 | GSTA4 | |
2944 | GSTM1 | glutathione S-transferase M1 | 1p13.3 | GSTM1 | |
2947 | GSTM3 | glutathione S-transferase M3 (brain) | 1p13.3 | GSTM3 | |
2950 | GSTP1 | glutathione S-transferase pi | 11q13 | GSTP1 | |
2952 | GSTT1 | glutathione S-transferase theta 1 | 22q11.23 | GSTT1 | |
2953 | GSTT2 | glutathione S-transferase theta 2 | 22q11.2|22q11.23 | GSTT2 | |
2993 | GYPA | glycophorin A (MNS blood group) | 4q28.2-q31.1 | GYPA | |
3015 | H2AFZ | H2A histone family, member Z | 4q24 | H2AFZ | |
9563 | H6PD | hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | 1p36 | H6PD | |
3033 | HADH | hydroxyacyl-Coenzyme A dehydrogenase | 4q22-q26 | HADH | |
3032 | HADHB | hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit | 2p23 | HADHB | |
3029 | HAGH | hydroxyacylglutathione hydrolase | 16p13.3 | HAGH | |
3034 | HAL | histidine ammonia-lyase | 12q22-q24.1 | HAL | |
57817 | HAMP | hepcidin antimicrobial peptide | 19q13.1 | HAMP | |
9001 | HAP1 | huntingtin-associated protein 1 | 17q21.2-q21.3 | HAP1 | |
3035 | HARS | histidyl-tRNA synthetase | 5q31.3 | HARS | |
3039 | HBA1 | hemoglobin, alpha 1 | 16p13.3 | HBA1 | |
3040 | HBA2 | hemoglobin, alpha 2 | 16p13.3 | HBA2 | |
3043 | HBB | hemoglobin, beta | 11p15.5 | HBB | |
3045 | HBD | hemoglobin, delta | 11p15.5 | HBD | |
3046 | HBE1 | hemoglobin, epsilon 1 | 11p15.5 | HBE1 | |
1839 | HBEGF | heparin-binding EGF-like growth factor | 5q23 | HBEGF | |
3042 | HBM | hemoglobin, mu | 16p13.3 | HBM | |
3050 | HBZ | hemoglobin, zeta | 16p13.3 | HBZ | |
3060 | HCRT | hypocretin (orexin) neuropeptide precursor | 17q21 | HCRT | |
3067 | HDC | histidine decarboxylase | 15q21-q22 | HDC | |
8916 | HERC3 | hect domain and RLD 3 | 4q21 | HERC3 | |
8820 | HESX1 | HESX homeobox 1 | 3p14.3 | HESX1 | |
3073 | HEXA | hexosaminidase A (alpha polypeptide) | 15q23-q24 | HEXA | |
3077 | HFE | hemochromatosis | 6p21.3 | HFE | |
3082 | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 7q21.1 | HGF | |
9146 | HGS | hepatocyte growth factor-regulated tyrosine kinase substrate | 17q25 | HGS | |
8357 | HIST1H3H | histone cluster 1, H3h | 6p22-p21.3 | HIST1H3H | |
3098 | HK1 | hexokinase 1 | 10q22 | HK1 | |
3099 | HK2 | hexokinase 2 | 2p13 | HK2 | |
3105 | HLA-A | major histocompatibility complex, class I, A | 6p21.3 | HLA-A | |
3106 | HLA-B | major histocompatibility complex, class I, B | 6p21.3 | HLA-B | |
3117 | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 6p21.3 | HLA-DQA1 | |
3119 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 6p21.3 | HLA-DQB1 | |
3123 | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 | 6p21.3 | HLA-DRB1 | |
3135 | HLA-G | major histocompatibility complex, class I, G | 6p21.3 | HLA-G | |
3131 | HLF | hepatic leukemia factor | 17q22 | HLF | |
3146 | HMGB1 | high-mobility group box 1 | 13q12 | HMGB1 | |
3148 | HMGB2 | high-mobility group box 2 | 4q31 | HMGB2 | |
3158 | HMGCS2 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) | 1p13-p12 | HMGCS2 | |
9324 | HMGN3 | high mobility group nucleosomal binding domain 3 | 6q14.1 | HMGN3 | |
6927 | HNF1A | HNF1 homeobox A | 12q22-qter|12q24.2 | HNF1A | |
3176 | HNMT | histamine N-methyltransferase | 2q22.1 | HNMT | |
3190 | HNRNPK | heterogeneous nuclear ribonucleoprotein K | 9q21.32-q21.33 | HNRNPK | |
9456 | HOMER1 | homer homolog 1 (Drosophila) | 5q14.2 | HOMER1 | |
9455 | HOMER2 | homer homolog 2 (Drosophila) | 15q24.3 | HOMER2 | |
3215 | HOXB5 | homeobox B5 | 17q21.3 | HOXB5 | |
3223 | HOXC6 | homeobox C6 | 12q13.3 | HOXC6 | |
3240 | HP | haptoglobin | 16q22.1 | HP | |
3208 | HPCA | hippocalcin | 1p35-p34.2 | HPCA | |
3242 | HPD | 4-hydroxyphenylpyruvate dioxygenase | 12q24-qter | HPD | |
3249 | HPN | hepsin (transmembrane protease, serine 1) | 19q11-q13.2 | HPN | |
3250 | HPR | haptoglobin-related protein | 16q22.1 | HPR | |
3251 | HPRT1 | hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) | Xq26.1 | HPRT1 | |
3263 | HPX | hemopexin | 11p15.5-p15.4 | HPX | |
3265 | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 11p15.5 | HRAS | |
3267 | HRB | HIV-1 Rev binding protein | 2q36.3 | HRB | |
3270 | HRC | histidine rich calcium binding protein | 19q13.3 | HRC | |
150274 | HSCB | HscB iron-sulfur cluster co-chaperone homolog (E. coli) | 22q12.1 | HSCB | |
3290 | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 1q32-q41 | HSD11B1 | |
3293 | HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 | 9q22 | HSD17B3 | |
3297 | HSF1 | heat shock transcription factor 1 | 8q24.3 | HSF1 | |
126393 | HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 19q13.12 | HSPB6 | |
26353 | HSPB8 | heat shock 22kDa protein 8 | 12q24.23 | HSPB8 | |
3350 | HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 5q11.2-q13 | HTR1A | |
3351 | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 6q13 | HTR1B | |
3356 | HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | 13q14-q21 | HTR2A | |
3358 | HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | Xq24 | HTR2C | |
3361 | HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A | 7q36.1 | HTR5A | |
3363 | HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 10q21-q24 | HTR7 | |
27429 | HTRA2 | HtrA serine peptidase 2 | 2p12 | HTRA2 | |
3064 | HTT | huntingtin | 4p16.3 | HTT | |
81888 | HYI | hydroxypyruvate isomerase homolog (E. coli) | 1p34.2 | HYI | |
285148 | IAH1 | isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae) | 2p25.1 | IAH1 | |
59082 | ICEBERG | - | 11q21-q22 | ICEBERG | |
3396 | ICT1 | immature colon carcinoma transcript 1 | 17q25.1 | ICT1 | |
3397 | ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 20q11 | ID1 | |
3398 | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 2p25 | ID2 | |
3416 | IDE | insulin-degrading enzyme | 10q23-q25 | IDE | |
3417 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 2q33.3 | IDH1 | |
3418 | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 15q26.1 | IDH2 | |
3423 | IDS | iduronate 2-sulfatase (Hunter syndrome) | Xq28 | IDS | |
3425 | IDUA | iduronidase, alpha-L- | 4p16.3 | IDUA | |
3454 | IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 21q22.1|21q22.11 | IFNAR1 | |
3458 | IFNG | interferon, gamma | 12q14 | IFNG | |
3479 | IGF1 | insulin-like growth factor 1 (somatomedin C) | 12q22-q23 | IGF1 | |
3480 | IGF1R | insulin-like growth factor 1 receptor | 15q26.3 | IGF1R | |
3481 | IGF2 | insulin-like growth factor 2 (somatomedin A) | 11p15.5 | IGF2 | |
3482 | IGF2R | insulin-like growth factor 2 receptor | 6q26 | IGF2R | |
3484 | IGFBP1 | insulin-like growth factor binding protein 1 | 7p13-p12 | IGFBP1 | |
3485 | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 2q33-q34 | IGFBP2 | |
3486 | IGFBP3 | insulin-like growth factor binding protein 3 | 7p13-p12 | IGFBP3 | |
3512 | IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 4q21 | IGJ | |
3586 | IL10 | interleukin 10 | 1q31-q32 | IL10 | |
3603 | IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 15q26.3 | IL16 | |
3606 | IL18 | interleukin 18 (interferon-gamma-inducing factor) | 11q22.2-q22.3 | IL18 | |
3552 | IL1A | interleukin 1, alpha | 2q14 | IL1A | |
3553 | IL1B | interleukin 1, beta | 2q14 | IL1B | |
3554 | IL1R1 | interleukin 1 receptor, type I | 2q12 | IL1R1 | |
3557 | IL1RN | interleukin 1 receptor antagonist | 2q14.2 | IL1RN | |
3558 | IL2 | interleukin 2 | 4q26-q27 | IL2 | |
3565 | IL4 | interleukin 4 | 5q31.1 | IL4 | |
3569 | IL6 | interleukin 6 (interferon, beta 2) | 7p21 | IL6 | |
3576 | IL8 | interleukin 8 | 4q13-q21 | IL8 | |
3611 | ILK | integrin-linked kinase | 11p15.5-p15.4 | ILK | |
9118 | INA | internexin neuronal intermediate filament protein, alpha | 10q24.33 | INA | |
440068 | INCA | - | 11q22.3 | INCA | |
3620 | INDO | indoleamine-pyrrole 2,3 dioxygenase | 8p12-p11 | INDO | |
64423 | INF2 | inverted formin, FH2 and WH2 domain containing | 14q32.33 | INF2 | |
3623 | INHA | inhibin, alpha | 2q33-q36 | INHA | |
3630 | INS | insulin | 11p15.5 | INS | |
10526 | IPO8 | importin 8 | 12p11.21 | IPO8 | |
3652 | IPP | intracisternal A particle-promoted polypeptide | 1p34-p32 | IPP | |
3664 | IRF6 | interferon regulatory factor 6 | 1q32.3-q41 | IRF6 | |
3667 | IRS1 | insulin receptor substrate 1 | 2q36 | IRS1 | |
8660 | IRS2 | insulin receptor substrate 2 | 13q34 | IRS2 | |
79192 | IRX1 | iroquois homeobox 1 | 5p15.3 | IRX1 | |
83737 | ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 20q11.22-q11.23 | ITCH | |
3655 | ITGA6 | integrin, alpha 6 | 2q31.1 | ITGA6 | |
3691 | ITGB4 | integrin, beta 4 | 17q25 | ITGB4 | |
3694 | ITGB6 | integrin, beta 6 | 2q24.2 | ITGB6 | |
3712 | IVD | isovaleryl Coenzyme A dehydrogenase | 15q14-q15 | IVD | |
3713 | IVL | involucrin | 1q21 | IVL | |
3716 | JAK1 | Janus kinase 1 (a protein tyrosine kinase) | 1p32.3-p31.3 | JAK1 | |
3717 | JAK2 | Janus kinase 2 (a protein tyrosine kinase) | 9p24 | JAK2 | |
3718 | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 19p13.1 | JAK3 | |
122953 | JDP2 | Jun dimerization protein 2 | 14q24.3 | JDP2 | |
8629 | JRK | jerky homolog (mouse) | 8q24.3 | JRK | |
3726 | JUNB | jun B proto-oncogene | 19p13.2 | JUNB | |
3727 | JUND | jun D proto-oncogene | 19p13.2 | JUND | |
3736 | KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 12p13.32 | KCNA1 | |
3741 | KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 12p13 | KCNA5 | |
3742 | KCNA6 | potassium voltage-gated channel, shaker-related subfamily, member 6 | 12p13 | KCNA6 | |
3778 | KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 10q22.3 | KCNMA1 | |
3785 | KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 20q13.3 | KCNQ2 | |
3791 | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 4q11-q12 | KDR | |
3792 | KEL | Kell blood group, metallo-endopeptidase | 7q33 | KEL | |
11081 | KERA | keratocan | 12q22 | KERA | |
22944 | KIN | KIN, antigenic determinant of recA protein homolog (mouse) | 10p15-p14 | KIN | |
9365 | KL | klotho | 13q12 | KL | |
25818 | KLK5 | kallikrein-related peptidase 5 | 19q13.3-q13.4 | KLK5 | |
5653 | KLK6 | kallikrein-related peptidase 6 | 19q13.3 | KLK6 | |
3856 | KRT8 | keratin 8 | 12q13 | KRT8 | |
3897 | L1CAM | L1 cell adhesion molecule | Xq28 | L1CAM | |
3898 | LAD1 | ladinin 1 | 1q25.1-q32.3 | LAD1 | |
3912 | LAMB1 | laminin, beta 1 | 7q22 | LAMB1 | |
51520 | LARS | leucyl-tRNA synthetase | 5q32 | LARS | |
27040 | LAT | linker for activation of T cells | 16p11.2 | LAT | |
3929 | LBP | lipopolysaccharide binding protein | 20q11.23-q12 | LBP | |
3931 | LCAT | lecithin-cholesterol acyltransferase | 16q22.1 | LCAT | |
3934 | LCN2 | lipocalin 2 | 9q34 | LCN2 | |
3938 | LCT | lactase | 2q21 | LCT | |
3939 | LDHA | lactate dehydrogenase A | 11p15.4 | LDHA | |
3945 | LDHB | lactate dehydrogenase B | 12p12.2-p12.1 | LDHB | |
197257 | LDHD | lactate dehydrogenase D | 16q23.1 | LDHD | |
3949 | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | 19p13.3 | LDLR | |
11061 | LECT1 | leukocyte cell derived chemotaxin 1 | 13q14-q21 | LECT1 | |
3950 | LECT2 | leukocyte cell-derived chemotaxin 2 | 5q31.1-q32 | LECT2 | |
3952 | LEP | leptin | 7q31.3 | LEP | |
3953 | LEPR | leptin receptor | 1p31 | LEPR | |
3972 | LHB | luteinizing hormone beta polypeptide | 19q13.32 | LHB | |
64077 | LHPP | - | 10q26.13 | LHPP | |
26468 | LHX6 | LIM homeobox 6 | 9q33.2 | LHX6 | |
3976 | LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 22q12.2 | LIF | |
3977 | LIFR | leukemia inhibitory factor receptor alpha | 5p13-p12 | LIFR | |
8994 | LIMD1 | LIM domains containing 1 | 3p21.3 | LIMD1 | |
3988 | LIPA | lipase A, lysosomal acid, cholesterol esterase (Wolman disease) | 10q23.2-q23.3 | LIPA | |
3990 | LIPC | lipase, hepatic | 15q21-q23 | LIPC | |
3991 | LIPE | lipase, hormone-sensitive | 19q13.2 | LIPE | |
149998 | LIPI | lipase, member I | 21q11.2 | LIPI | |
3997 | LLP | lactation, late, protein (macropodids) | - | LLP | |
4014 | LOR | loricrin | 1q21 | LOR | |
4015 | LOX | lysyl oxidase | 5q23.2 | LOX | |
4017 | LOXL2 | lysyl oxidase-like 2 | 8p21.3-p21.2 | LOXL2 | |
4018 | LPA | lipoprotein, Lp(a) | 6q26 | LPA | |
4023 | LPL | lipoprotein lipase | 8p22 | LPL | |
4025 | LPO | lactoperoxidase | 17q23.1 | LPO | |
4026 | LPP | LIM domain containing preferred translocation partner in lipoma | 3q28 | LPP | |
9227 | LRAT | lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) | 4q32.1 | LRAT | |
987 | LRBA | LPS-responsive vesicle trafficking, beach and anchor containing | 4q31.3 | LRBA | |
4041 | LRP5 | low density lipoprotein receptor-related protein 5 | 11q13.4 | LRP5 | |
4046 | LSP1 | lymphocyte-specific protein 1 | 11p15.5 | LSP1 | |
4047 | LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 21q22.3 | LSS | |
4049 | LTA | lymphotoxin alpha (TNF superfamily, member 1) | 6p21.3 | LTA | |
4050 | LTB | lymphotoxin beta (TNF superfamily, member 3) | 6p21.3 | LTB | |
4057 | LTF | lactotransferrin | 3p21.31 | LTF | |
4058 | LTK | leukocyte receptor tyrosine kinase | 15q15.1-q21.1 | LTK | |
4060 | LUM | lumican | 12q21.3-q22 | LUM | |
4061 | LY6E | lymphocyte antigen 6 complex, locus E | 8q24.3 | LY6E | |
4067 | LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 8q13 | LYN | |
4074 | M6PR | mannose-6-phosphate receptor (cation dependent) | 12p13 | M6PR | |
8567 | MADD | MAP-kinase activating death domain | 11p11.2 | MADD | |
10296 | MAEA | macrophage erythroblast attacher | 4p16.3 | MAEA | |
4094 | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 16q22-q23 | MAF | |
84232 | MAF1 | MAF1 homolog (S. cerevisiae) | 8q24.3 | MAF1 | |
9935 | MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 20q11.2-q13.1 | MAFB | |
4099 | MAG | myelin associated glycoprotein | 19q13.1 | MAG | |
4117 | MAK | male germ cell-associated kinase | 6p24 | MAK | |
60560 | MAK10 | MAK10 homolog, amino-acid N-acetyltransferase subunit (S. cerevisiae) | 9q21.33 | MAK10 | |
4118 | MAL | mal, T-cell differentiation protein | 2cen-q13 | MAL | |
114569 | MAL2 | mal, T-cell differentiation protein 2 | 8q23 | MAL2 | |
7851 | MALL | mal, T-cell differentiation protein-like | 2q13 | MALL | |
79694 | MANEA | mannosidase, endo-alpha | 6q16.1 | MANEA | |
4128 | MAOA | monoamine oxidase A | Xp11.3 | MAOA | |
4129 | MAOB | monoamine oxidase B | Xp11.23 | MAOB | |
4131 | MAP1B | microtubule-associated protein 1B | 5q13 | MAP1B | |
4133 | MAP2 | microtubule-associated protein 2 | 2q34-q35 | MAP2 | |
4215 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 17q23.3 | MAP3K3 | |
5594 | MAPK1 | mitogen-activated protein kinase 1 | 22q11.2|22q11.21 | MAPK1 | |
4082 | MARCKS | myristoylated alanine-rich protein kinase C substrate | 6q22.2 | MARCKS | |
8685 | MARCO | macrophage receptor with collagenous structure | 2q12-q13 | MARCO | |
4139 | MARK1 | MAP/microtubule affinity-regulating kinase 1 | 1q41 | MARK1 | |
2011 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | 11q12-q13 | MARK2 | |
57787 | MARK4 | MAP/microtubule affinity-regulating kinase 4 | 19q13.3 | MARK4 | |
4141 | MARS | methionyl-tRNA synthetase | 12q13.2 | MARS | |
4142 | MAS1 | MAS1 oncogene | 6q25.3-q26 | MAS1 | |
4143 | MAT1A | methionine adenosyltransferase I, alpha | 10q22 | MAT1A | |
4144 | MAT2A | methionine adenosyltransferase II, alpha | 2p11.2 | MAT2A | |
4145 | MATK | megakaryocyte-associated tyrosine kinase | 19p13.3 | MATK | |
4150 | MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | 16p11.2 | MAZ | |
4151 | MB | myoglobin | 22q13.1 | MB | |
4153 | MBL2 | mannose-binding lectin (protein C) 2, soluble (opsonic defect) | 10q11.2-q21 | MBL2 | |
4155 | MBP | myelin basic protein | 18q23 | MBP | |
4159 | MC3R | melanocortin 3 receptor | 20q13.2-q13.3 | MC3R | |
4160 | MC4R | melanocortin 4 receptor | 18q22 | MC4R | |
4163 | MCC | mutated in colorectal cancers | 5q21 | MCC | |
2847 | MCHR1 | melanin-concentrating hormone receptor 1 | 22q13.2 | MCHR1 | |
4171 | MCM2 | minichromosome maintenance complex component 2 | 3q21 | MCM2 | |
4178 | MCO | microphthalmia (Los Angeles type) | - | MCO | |
4190 | MDH1 | malate dehydrogenase 1, NAD (soluble) | 2p13.3 | MDH1 | |
4191 | MDH2 | malate dehydrogenase 2, NAD (mitochondrial) | 7cen-q22 | MDH2 | |
4193 | MDM2 | Mdm2 p53 binding protein homolog (mouse) | 12q14.3-q15 | MDM2 | |
4194 | MDM4 | Mdm4 p53 binding protein homolog (mouse) | 1q32 | MDM4 | |
4199 | ME1 | malic enzyme 1, NADP(+)-dependent, cytosolic | 6q12 | ME1 | |
4200 | ME2 | malic enzyme 2, NAD(+)-dependent, mitochondrial | 6p25-p24|18q21 | ME2 | |
10873 | ME3 | malic enzyme 3, NADP(+)-dependent, mitochondrial | 11cen-q22.3 | ME3 | |
4204 | MECP2 | methyl CpG binding protein 2 (Rett syndrome) | Xq28 | MECP2 | |
51586 | MED15 | mediator complex subunit 15 | 22q11.2 | MED15 | |
4210 | MEFV | Mediterranean fever | 16p13.3 | MEFV | |
9833 | MELK | maternal embryonic leucine zipper kinase | 9p13.2 | MELK | |
4221 | MEN1 | multiple endocrine neoplasia I | 11q13 | MEN1 | |
4232 | MEST | mesoderm specific transcript homolog (mouse) | 7q32 | MEST | |
4233 | MET | met proto-oncogene (hepatocyte growth factor receptor) | 7q31 | MET | |
23269 | MGA | MAX gene associated | 15q14 | MGA | |
11343 | MGLL | monoglyceride lipase | 3q21.3 | MGLL | |
4255 | MGMT | O-6-methylguanine-DNA methyltransferase | 10q26 | MGMT | |
4256 | MGP | matrix Gla protein | 12p13.1-p12.3 | MGP | |
8190 | MIA | melanoma inhibitory activity | 19q13.32-q13.33 | MIA | |
57534 | MIB1 | mindbomb homolog 1 (Drosophila) | 18q11.2 | MIB1 | |
4276 | MICA | MHC class I polypeptide-related sequence A | 6p21.3 | MICA | |
4282 | MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 22q11.23 | MIF | |
84864 | MINA | MYC induced nuclear antigen | 3q11.2 | MINA | |
4284 | MIP | major intrinsic protein of lens fiber | 12q13 | MIP | |
116449 | MIST | - | 4p16.1 | MIST | |
4291 | MLF1 | myeloid leukemia factor 1 | 3q25.1 | MLF1 | |
4292 | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) | 3p21.3 | MLH1 | |
4297 | MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 11q23 | MLL | |
4295 | MLN | motilin | 6p21.3 | MLN | |
6945 | MLX | MAX-like protein X | 17q21.1 | MLX | |
166785 | MMAA | methylmalonic aciduria (cobalamin deficiency) cblA type | 4q31.22 | MMAA | |
23531 | MMD | monocyte to macrophage differentiation-associated | 17q | MMD | |
4311 | MME | membrane metallo-endopeptidase | 3q25.1-q25.2 | MME | |
4312 | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 11q22.3 | MMP1 | |
4322 | MMP13 | matrix metallopeptidase 13 (collagenase 3) | 11q22.3 | MMP13 | |
4313 | MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 16q13-q21 | MMP2 | |
4314 | MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 11q22.3 | MMP3 | |
4318 | MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 20q11.2-q13.1 | MMP9 | |
4330 | MN1 | meningioma (disrupted in balanced translocation) 1 | 22q11|22q12.1 | MN1 | |
4335 | MNT | MAX binding protein | 17p13.3 | MNT | |
4336 | MOBP | myelin-associated oligodendrocyte basic protein | 3p22.1 | MOBP | |
4340 | MOG | myelin oligodendrocyte glycoprotein | 6p22.1 | MOG | |
4342 | MOS | v-mos Moloney murine sarcoma viral oncogene homolog | 8q11 | MOS | |
8777 | MPDZ | multiple PDZ domain protein | 9p24-p22 | MPDZ | |
4350 | MPG | N-methylpurine-DNA glycosylase | 16p13.3 | MPG | |
4351 | MPI | mannose phosphate isomerase | 15q22-qter | MPI | |
4352 | MPL | myeloproliferative leukemia virus oncogene | 1p34 | MPL | |
339501 | MPN2 | - | 1q42.13 | MPN2 | |
4353 | MPO | myeloperoxidase | 17q23.1 | MPO | |
4358 | MPV17 | MpV17 mitochondrial inner membrane protein | 2p23.3 | MPV17 | |
3140 | MR1 | major histocompatibility complex, class I-related | 1q25.3 | MR1 | |
64965 | MRPS9 | mitochondrial ribosomal protein S9 | 2q12.1 | MRPS9 | |
9242 | MSC | musculin (activated B-cell factor-1) | 8q21 | MSC | |
339287 | MSL-1 | - | 17q21.1 | MSL-1 | |
4478 | MSN | moesin | Xq11.2-q12 | MSN | |
4487 | MSX1 | msh homeobox 1 | 4p16.3-p16.1 | MSX1 | |
4488 | MSX2 | msh homeobox 2 | 5q34-q35 | MSX2 | |
4495 | MT1G | metallothionein 1G | 16q13 | MT1G | |
84560 | MT4 | metallothionein 4 | 16q13 | MT4 | |
92140 | MTDH | metadherin | 8q22.1 | MTDH | |
4522 | MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase | 14q24 | MTHFD1 | |
4524 | MTHFR | 5,10-methylenetetrahydrofolate reductase (NADPH) | 1p36.3 | MTHFR | |
4548 | MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 1q43 | MTR | |
4552 | MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 5p15.3-p15.2 | MTRR | |
4582 | MUC1 | mucin 1, cell surface associated | 1q21 | MUC1 | |
4583 | MUC2 | mucin 2, oligomeric mucus/gel-forming | 11p15.5 | MUC2 | |
4586 | MUC5AC | mucin 5AC, oligomeric mucus/gel-forming | 11p15.5 | MUC5AC | |
4588 | MUC6 | mucin 6, oligomeric mucus/gel-forming | 11p15.5-p15.4 | MUC6 | |
4593 | MUSK | muscle, skeletal, receptor tyrosine kinase | 9q31.3-q32 | MUSK | |
4594 | MUT | methylmalonyl Coenzyme A mutase | 6p12.3 | MUT | |
63915 | MUTED | muted homolog (mouse) | 6p25.1-p24.3 | MUTED | |
4595 | MUTYH | mutY homolog (E. coli) | 1p34.3-p32.1 | MUTYH | |
4597 | MVD | mevalonate (diphospho) decarboxylase | 16q24.3 | MVD | |
4598 | MVK | mevalonate kinase | 12q24 | MVK | |
9961 | MVP | major vault protein | 16p13.1-p11.2 | MVP | |
4599 | MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 21q22.3 | MX1 | |
4602 | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 6q22-q23 | MYB | |
4609 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 8q24.21 | MYC | |
4613 | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 2p24.1 | MYCN | |
4625 | MYH7 | myosin, heavy chain 7, cardiac muscle, beta | 14q12 | MYH7 | |
4653 | MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 1q23-q24 | MYOC | |
4666 | NACA | nascent polypeptide-associated complex alpha subunit | 12q23-q24.1 | NACA | |
51594 | NAG | - | 2p24 | NAG | |
4668 | NAGA | N-acetylgalactosaminidase, alpha- | 22q13-qter|22q11 | NAGA | |
79923 | NANOG | Nanog homeobox | 12p13.31 | NANOG | |
140838 | NANP | N-acetylneuraminic acid phosphatase | 20p11.1 | NANP | |
8775 | NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 19q13.32 | NAPA | |
4678 | NASP | nuclear autoantigenic sperm protein (histone-binding) | 1p34.1 | NASP | |
9 | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | 8p23.1-p21.3 | NAT1 | |
10 | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 8p22 | NAT2 | |
89796 | NAV1 | neuron navigator 1 | 1q32.3 | NAV1 | |
83988 | NCALD | neurocalcin delta | 8q22.2 | NCALD | |
4684 | NCAM1 | neural cell adhesion molecule 1 | 11q23.1 | NCAM1 | |
4691 | NCL | nucleolin | 2q12-qter | NCL | |
4535 | ND1 | mitochondrially encoded NADH dehydrogenase 1 | - | ND1 | |
4536 | ND2 | mitochondrially encoded NADH dehydrogenase 2 | - | ND2 | |
4537 | ND3 | mitochondrially encoded NADH dehydrogenase 3 | - | ND3 | |
4538 | ND4 | mitochondrially encoded NADH dehydrogenase 4 | - | ND4 | |
4540 | ND5 | mitochondrially encoded NADH dehydrogenase 5 | - | ND5 | |
4541 | ND6 | mitochondrially encoded NADH dehydrogenase 6 | - | ND6 | |
54820 | NDE1 | nudE nuclear distribution gene E homolog 1 (A. nidulans) | 16p13.11 | NDE1 | |
4693 | NDP | Norrie disease (pseudoglioma) | Xp11.4 | NDP | |
4703 | NEB | nebulin | 2q22 | NEB | |
4744 | NEFH | neurofilament, heavy polypeptide 200kDa | 22q12.2 | NEFH | |
10763 | NES | nestin | 1q23.1 | NES | |
4758 | NEU1 | sialidase 1 (lysosomal sialidase) | 6p21.3 | NEU1 | |
4763 | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 17q11.2 | NF1 | |
4771 | NF2 | neurofibromin 2 (merlin) | 22q12.2 | NF2 | |
4790 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 4q24 | NFKB1 | |
58157 | NGB | neuroglobin | 14q24.3 | NGB | |
4803 | NGF | nerve growth factor (beta polypeptide) | 1p13.1 | NGF | |
4804 | NGFR | nerve growth factor receptor (TNFR superfamily, member 16) | 17q21-q22 | NGFR | |
4810 | NHS | Nance-Horan syndrome (congenital cataracts and dental anomalies) | Xp22.13 | NHS | |
84276 | NICN1 | nicolin 1 | 3p21.31 | NICN1 | |
7080 | NKX2-1 | NK2 homeobox 1 | 14q13 | NKX2-1 | |
51701 | NLK | nemo-like kinase | 17q11.2 | NLK | |
4828 | NMB | neuromedin B | 15q22-qter | NMB | |
4831 | NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 17q21.3 | NME2 | |
4833 | NME4 | non-metastatic cells 4, protein expressed in | 16p13.3 | NME4 | |
9111 | NMI | N-myc (and STAT) interactor | 2q23 | NMI | |
349565 | NMNAT3 | nicotinamide nucleotide adenylyltransferase 3 | 3q23 | NMNAT3 | |
129521 | NMS | neuromedin S | 2q11.2 | NMS | |
4836 | NMT1 | N-myristoyltransferase 1 | 17q21.31 | NMT1 | |
10874 | NMU | neuromedin U | 4q12 | NMU | |
4837 | NNMT | nicotinamide N-methyltransferase | 11q23.1 | NNMT | |
23530 | NNT | nicotinamide nucleotide transhydrogenase | 5p13.1-cen | NNT | |
4838 | NODAL | nodal homolog (mouse) | 10q22.1 | NODAL | |
9241 | NOG | noggin | 17q21-q22 | NOG | |
4841 | NONO | non-POU domain containing, octamer-binding | Xq13.1 | NONO | |
4842 | NOS1 | nitric oxide synthase 1 (neuronal) | 12q24.2-q24.31 | NOS1 | |
4843 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | 17q11.2-q12 | NOS2A | |
4846 | NOS3 | nitric oxide synthase 3 (endothelial cell) | 7q36 | NOS3 | |
4851 | NOTCH1 | Notch homolog 1, translocation-associated (Drosophila) | 9q34.3 | NOTCH1 | |
4855 | NOTCH4 | Notch homolog 4 (Drosophila) | 6p21.3 | NOTCH4 | |
344022 | NOTO | notochord homeobox | 2p13.2 | NOTO | |
27035 | NOX1 | NADPH oxidase 1 | Xq22 | NOX1 | |
50507 | NOX4 | NADPH oxidase 4 | 11q14.2-q21 | NOX4 | |
124056 | NOXO1 | NADPH oxidase organizer 1 | 16p13.3 | NOXO1 | |
4860 | NP | nucleoside phosphorylase | 14q13.1 | NP | |
64067 | NPAS3 | neuronal PAS domain protein 3 | 14q12-q13 | NPAS3 | |
256933 | NPB | neuropeptide B | 17q25.3 | NPB | |
8620 | NPFF | neuropeptide FF-amide peptide precursor | 12q13.13 | NPFF | |
9284 | NPIP | nuclear pore complex interacting protein | 16p13-p11 | NPIP | |
80896 | NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 1q25 | NPL | |
4879 | NPPB | natriuretic peptide precursor B | 1p36.2 | NPPB | |
594857 | NPS | neuropeptide S | 10q26.2 | NPS | |
4852 | NPY | neuropeptide Y | 7p15.1 | NPY | |
4886 | NPY1R | neuropeptide Y receptor Y1 | 4q31.3-q32 | NPY1R | |
4887 | NPY2R | neuropeptide Y receptor Y2 | 4q31 | NPY2R | |
4889 | NPY5R | neuropeptide Y receptor Y5 | 4q31-q32 | NPY5R | |
1728 | NQO1 | NAD(P)H dehydrogenase, quinone 1 | 16q22.1 | NQO1 | |
4835 | NQO2 | NAD(P)H dehydrogenase, quinone 2 | 6pter-q12 | NQO2 | |
3164 | NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 12q13 | NR4A1 | |
4929 | NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 2q22-q23 | NR4A2 | |
4893 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 1p13.2 | NRAS | |
4897 | NRCAM | neuronal cell adhesion molecule | 7q31.1-q31.2 | NRCAM | |
3084 | NRG1 | neuregulin 1 | 8p12 | NRG1 | |
203447 | NRK | Nik related kinase | Xq22.3 | NRK | |
4901 | NRL | neural retina leucine zipper | 14q11.1-q11.2 | NRL | |
9378 | NRXN1 | neurexin 1 | 2p16.3 | NRXN1 | |
9369 | NRXN3 | neurexin 3 | 14q31 | NRXN3 | |
4905 | NSF | N-ethylmaleimide-sensitive factor | 17q21 | NSF | |
4877 | NT3 | 3'-nucleotidase | - | NT3 | |
4915 | NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 9q22.1 | NTRK2 | |
4922 | NTS | neurotensin | 12q21 | NTS | |
23620 | NTSR2 | neurotensin receptor 2 | 2p25.1 | NTSR2 | |
4521 | NUDT1 | nudix (nucleoside diphosphate linked moiety X)-type motif 1 | 7p22 | NUDT1 | |
53343 | NUDT9 | nudix (nucleoside diphosphate linked moiety X)-type motif 9 | 4q22.1 | NUDT9 | |
8650 | NUMB | numb homolog (Drosophila) | 14q24.3 | NUMB | |
64359 | NXN | nucleoredoxin | 17p13.3 | NXN | |
4942 | OAT | ornithine aminotransferase (gyrate atrophy) | 10q26 | OAT | |
654231 | OCM | oncomodulin | 7p22.1 | OCM | |
54959 | ODAM | odontogenic, ameloblast asssociated | 4q13.3 | ODAM | |
4968 | OGG1 | 8-oxoguanine DNA glycosylase | 3p26.2 | OGG1 | |
8473 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) | Xq13 | OGT | |
55301 | OLAH | oleoyl-ACP hydrolase | 10p13 | OLAH | |
4958 | OMD | osteomodulin | 9q22.31 | OMD | |
4974 | OMG | oligodendrocyte myelin glycoprotein | 17q11.2 | OMG | |
4975 | OMP | olfactory marker protein | 11q13.5 | OMP | |
4976 | OPA1 | optic atrophy 1 (autosomal dominant) | 3q28-q29|3q28-q29 | OPA1 | |
4985 | OPRD1 | opioid receptor, delta 1 | 1p36.1-p34.3 | OPRD1 | |
4986 | OPRK1 | opioid receptor, kappa 1 | 8q11.2 | OPRK1 | |
4987 | OPRL1 | opiate receptor-like 1 | 20q13.33 | OPRL1 | |
4988 | OPRM1 | opioid receptor, mu 1 | 6q24-q25 | OPRM1 | |
55354 | ORF1 | - | 18q23 | ORF1 | |
84709 | OSAP | - | 4q31.1 | OSAP | |
126014 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 19q13.42 | OSCAR | |
5008 | OSM | oncostatin M | 22q12.2 | OSM | |
5009 | OTC | ornithine carbamoyltransferase | Xp21.1 | OTC | |
5015 | OTX2 | orthodenticle homeobox 2 | 14q21-q22 | OTX2 | |
5020 | OXT | oxytocin, prepro- (neurophysin I) | 20p13 | OXT | |
8909 | P11 | - | 12q13.1 | P11 | |
5033 | P4HA1 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide I | 10q21.3-q23.1 | P4HA1 | |
196463 | P76 | - | 12q24.13 | P76 | |
54623 | PAF1 | Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) | 19q13.1 | PAF1 | |
55824 | PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 8q21.13 | PAG1 | |
5053 | PAH | phenylalanine hydroxylase | 12q22-q24.2 | PAH | |
5058 | PAK1 | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 11q13-q14 | PAK1 | |
5062 | PAK2 | p21 (CDKN1A)-activated kinase 2 | 3q29 | PAK2 | |
5063 | PAK3 | p21 (CDKN1A)-activated kinase 3 | Xq22.3 | PAK3 | |
5064 | PALM | paralemmin | 19p13.3 | PALM | |
5066 | PAM | peptidylglycine alpha-amidating monooxygenase | 5q14-q21 | PAM | |
196743 | PAOX | polyamine oxidase (exo-N4-amino) | 10q26.3 | PAOX | |
23113 | PARC | - | 6p21.1 | PARC | |
55486 | PARL | presenilin associated, rhomboid-like | 3q27.1 | PARL | |
142 | PARP1 | poly (ADP-ribose) polymerase family, member 1 | 1q41-q42 | PARP1 | |
55742 | PARVA | parvin, alpha | 11p15.3 | PARVA | |
5076 | PAX2 | paired box 2 | 10q24 | PAX2 | |
5077 | PAX3 | paired box 3 | 2q35-q37|2q35 | PAX3 | |
5079 | PAX5 | paired box 5 | 9p13 | PAX5 | |
5080 | PAX6 | paired box 6 | 11p13 | PAX6 | |
5087 | PBX1 | pre-B-cell leukemia homeobox 1 | 1q23 | PBX1 | |
5091 | PC | pyruvate carboxylase | 11q13.4-q13.5 | PC | |
692094 | PC-3 | - | 9p13.3 | PC-3 | |
8850 | PCAF | p300/CBP-associated factor | 3p24 | PCAF | |
5095 | PCCA | propionyl Coenzyme A carboxylase, alpha polypeptide | 13q32 | PCCA | |
5100 | PCDH8 | protocadherin 8 | 13q14.3-q21.1 | PCDH8 | |
5105 | PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 20q13.31 | PCK1 | |
5111 | PCNA | proliferating cell nuclear antigen | 20pter-p12 | PCNA | |
5121 | PCP4 | Purkinje cell protein 4 | 21q22.2 | PCP4 | |
5132 | PDC | phosducin | 1q25.2 | PDC | |
5082 | PDCL | phosducin-like | 9q12-q13 | PDCL | |
132954 | PDCL2 | phosducin-like 2 | 4q12 | PDCL2 | |
64146 | peptide deformylase (mitochondrial) | 16q22.1 | |||
5154 | PDGFA | platelet-derived growth factor alpha polypeptide | 7p22 | PDGFA | |
5155 | PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 22q12.3-q13.1|22q13.1 | PDGFB | |
5162 | PDHB | pyruvate dehydrogenase (lipoamide) beta | 3p21.1-p14.2 | PDHB | |
2923 | PDIA3 | protein disulfide isomerase family A, member 3 | 15q15 | PDIA3 | |
5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 2q31.1 | PDK1 | |
5166 | PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | 7q21.3 | PDK4 | |
3651 | PDX1 | pancreatic and duodenal homeobox 1 | 13q12.1 | PDX1 | |
8566 | PDXK | pyridoxal (pyridoxine, vitamin B6) kinase | 21q22.3 | PDXK | |
5173 | PDYN | prodynorphin | 20pter-p12 | PDYN | |
53918 | PELO | pelota homolog (Drosophila) | 5q11.2 | PELO | |
10400 | PEMT | phosphatidylethanolamine N-methyltransferase | 17p11.2 | PEMT | |
5179 | PENK | proenkephalin | 8q23-q24 | PENK | |
5183 | PEPC | peptidase C | 1q25 | PEPC | |
5187 | PER1 | period homolog 1 (Drosophila) | 17p13.1-p12 | PER1 | |
8864 | PER2 | period homolog 2 (Drosophila) | 2q37.3 | PER2 | |
8863 | PER3 | period homolog 3 (Drosophila) | 1p36.23 | PER3 | |
64065 | PERP | PERP, TP53 apoptosis effector | 6q24 | PERP | |
5189 | PEX1 | peroxisome biogenesis factor 1 | 7q21.2 | PEX1 | |
5192 | PEX10 | peroxisome biogenesis factor 10 | 1p36.32 | PEX10 | |
5195 | PEX14 | peroxisomal biogenesis factor 14 | 1p36.22 | PEX14 | |
8504 | PEX3 | peroxisomal biogenesis factor 3 | 6q23-q24 | PEX3 | |
5830 | PEX5 | peroxisomal biogenesis factor 5 | 12p13.3 | PEX5 | |
5196 | PF4 | platelet factor 4 (chemokine (C-X-C motif) ligand 4) | 4q12-q21 | PF4 | |
5198 | PFAS | phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) | 17p13.1 | PFAS | |
5213 | PFKM | phosphofructokinase, muscle | 12q13.3 | PFKM | |
5216 | PFN1 | profilin 1 | 17p13.3 | PFN1 | |
345456 | PFN3 | profilin 3 | 5q35.3 | PFN3 | |
375189 | PFN4 | profilin family, member 4 | 2p23.3 | PFN4 | |
5225 | PGC | progastricsin (pepsinogen C) | 6p21.3-p21.1 | PGC | |
5226 | PGD | phosphogluconate dehydrogenase | 1p36.3-p36.13 | PGD | |
27306 | PGDS | - | 4q22.3 | PGDS | |
5228 | PGF | placental growth factor | 14q24-q31 | PGF | |
5230 | PGK1 | phosphoglycerate kinase 1 | Xq13 | PGK1 | |
5236 | PGM1 | phosphoglucomutase 1 | 1p31 | PGM1 | |
55276 | PGM2 | phosphoglucomutase 2 | 4p14 | PGM2 | |
5240 | PGP | phosphoglycolate phosphatase | 16p13.3 | PGP | |
5241 | PGR | progesterone receptor | 11q22-q23 | PGR | |
9489 | PGS1 | phosphatidylglycerophosphate synthase 1 | 17q25.3 | PGS1 | |
5245 | PHB | prohibitin | 17q21 | PHB | |
11331 | PHB2 | prohibitin 2 | 12p13 | PHB2 | |
5251 | PHEX | phosphate regulating endopeptidase homolog, X-linked (hypophosphatemia, vitamin D resistant rickets) | Xp22.2-p22.1 | PHEX | |
55023 | PHIP | pleckstrin homology domain interacting protein | 6q14 | PHIP | |
5266 | PI3 | peptidase inhibitor 3, skin-derived (SKALP) | 20q12-q13 | PI3 | |
10401 | PIAS3 | protein inhibitor of activated STAT, 3 | 1q21 | PIAS3 | |
5284 | PIGR | polymeric immunoglobulin receptor | 1q31-q41 | PIGR | |
5285 | PIH | pregnancy-induced hypertension (pre-eclampsia, eclampsia, toxemia of pregnancy included) | - | PIH | |
5295 | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 5q13.1 | PIK3R1 | |
5292 | PIM1 | pim-1 oncogene | 6p21.2 | PIM1 | |
11040 | PIM2 | pim-2 oncogene | Xp11.23 | PIM2 | |
5300 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 19p13 | PIN1 | |
5304 | PIP | prolactin-induced protein | 7q34 | PIP | |
8544 | PIR | pirin (iron-binding nuclear protein) | Xp22.2 | PIR | |
5310 | PKD1 | polycystic kidney disease 1 (autosomal dominant) | 16p13.3 | PKD1 | |
5311 | PKD2 | polycystic kidney disease 2 (autosomal dominant) | 4q21-q23 | PKD2 | |
5569 | PKIA | protein kinase (cAMP-dependent, catalytic) inhibitor alpha | 8q21.12 | PKIA | |
63876 | PKNOX2 | PBX/knotted 1 homeobox 2 | - | PKNOX2 | |
5317 | PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 1q32 | PKP1 | |
5327 | PLAT | plasminogen activator, tissue | 8p12 | PLAT | |
5328 | PLAU | plasminogen activator, urokinase | 10q24 | PLAU | |
5329 | PLAUR | plasminogen activator, urokinase receptor | 19q13 | PLAUR | |
151056 | PLB1 | phospholipase B1 | 2p23.2 | PLB1 | |
5337 | PLD1 | phospholipase D1, phosphatidylcholine-specific | 3q26 | PLD1 | |
5338 | PLD2 | phospholipase D2 | 17p13.1 | PLD2 | |
5340 | PLG | plasminogen | 6q26 | PLG | |
5346 | PLIN | perilipin | 15q26 | PLIN | |
5350 | PLN | phospholamban | 6q22.1 | PLN | |
5354 | PLP1 | proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated) | Xq22 | PLP1 | |
5357 | PLS1 | plastin 1 (I isoform) | 3q23 | PLS1 | |
5360 | PLTP | phospholipid transfer protein | 20q12-q13.1 | PLTP | |
51297 | PLUNC | palate, lung and nasal epithelium associated | 20q11.2 | PLUNC | |
5371 | PML | promyelocytic leukemia | 15q22 | PML | |
5376 | PMP22 | peripheral myelin protein 22 | 17p12-p11.2 | PMP22 | |
25953 | PNKD | paroxysmal nonkinesigenic dyskinesia | 2q35 | PNKD | |
5409 | PNMT | phenylethanolamine N-methyltransferase | 17q21-q22 | PNMT | |
5411 | PNN | pinin, desmosome associated protein | 14q21.1 | PNN | |
5368 | PNOC | prepronociceptin | 8p21 | PNOC | |
55163 | PNPO | pyridoxamine 5'-phosphate oxidase | 17q21.32 | PNPO | |
5422 | POLA1 | polymerase (DNA directed), alpha 1 | Xp22.1-p21.3 | POLA1 | |
5423 | POLB | polymerase (DNA directed), beta | 8p11.2 | POLB | |
5426 | POLE | polymerase (DNA directed), epsilon | 12q24.3 | POLE | |
11232 | POLG2 | polymerase (DNA directed), gamma 2, accessory subunit | 17q | POLG2 | |
11201 | POLI | polymerase (DNA directed) iota | 18q21.1 | POLI | |
51426 | POLK | polymerase (DNA directed) kappa | 5q13 | POLK | |
27343 | POLL | polymerase (DNA directed), lambda | 10q23 | POLL | |
5430 | POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 17p13.1 | POLR2A | |
11044 | POLS | polymerase (DNA directed) sigma | 5p15 | POLS | |
5443 | POMC | proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) | 2p23.3 | POMC | |
5444 | PON1 | paraoxonase 1 | 7q21.3 | PON1 | |
5447 | POR | P450 (cytochrome) oxidoreductase | 7q11.2 | POR | |
25913 | POT1 | POT1 protection of telomeres 1 homolog (S. pombe) | 7q31.33 | POT1 | |
5465 | PPARA | peroxisome proliferator-activated receptor alpha | 22q12-q13.1|22q13.31 | PPARA | |
5468 | PPARG | peroxisome proliferator-activated receptor gamma | 3p25 | PPARG | |
5473 | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 4q12-q13 | PPBP | |
79717 | PPCS | phosphopantothenoylcysteine synthetase | 1p34.2 | PPCS | |
5478 | PPIA | peptidylprolyl isomerase A (cyclophilin A) | 7p13 | PPIA | |
5479 | PPIB | peptidylprolyl isomerase B (cyclophilin B) | 15q21-q22 | PPIB | |
5493 | PPL | periplakin | 16p13.3 | PPL | |
5538 | PPT1 | palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) | 1p32 | PPT1 | |
5539 | PPY | pancreatic polypeptide | 17q21 | PPY | |
9055 | PRC1 | protein regulator of cytokinesis 1 | 15q26.1 | PRC1 | |
25824 | PRDX5 | peroxiredoxin 5 | 11q13 | PRDX5 | |
10113 | PREB | prolactin regulatory element binding | 2p23.3 | PREB | |
5550 | PREP | prolyl endopeptidase | 6q22 | PREP | |
5578 | PRKCA | protein kinase C, alpha | 17q22-q23.2 | PRKCA | |
5582 | PRKCG | protein kinase C, gamma | 19q13.4 | PRKCG | |
5617 | PRL | prolactin | 6p22.2-p21.3 | PRL | |
5619 | PRM1 | protamine 1 | 16p13.2 | PRM1 | |
5621 | PRNP | prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | 20p13 | PRNP | |
353215 | PRO1 | progeria 1 (Hutchinson-Gilford type) | - | PRO1 | |
5624 | PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 2q13-q14 | PROC | |
5626 | PROP1 | PROP paired-like homeobox 1 | 5q35.3 | PROP1 | |
5644 | PRSS1 | protease, serine, 1 (trypsin 1) | 7q32-qter|7q34 | PRSS1 | |
58497 | PRUNE | prune homolog (Drosophila) | 1q21 | PRUNE | |
57716 | PRX | periaxin | 19q13.13-q13.2 | PRX | |
9081 | PRY | PTPN13-like, Y-linked | Yq11.223 | PRY | |
442862 | PRY2 | PTPN13-like, Y-linked 2 | Yq11.223 | PRY2 | |
5660 | PSAP | prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) | 10q21-q22 | PSAP | |
5662 | PSD | pleckstrin and Sec7 domain containing | 10q24 | PSD | |
5663 | PSEN1 | presenilin 1 (Alzheimer disease 3) | 14q24.3 | PSEN1 | |
5673 | PSG5 | pregnancy specific beta-1-glycoprotein 5 | 19q13.2 | PSG5 | |
5728 | PTEN | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 10q23.3 | PTEN | |
9317 | PTER | phosphotriesterase related | 10p12 | PTER | |
5731 | PTGER1 | prostaglandin E receptor 1 (subtype EP1), 42kDa | 19p13.1 | PTGER1 | |
5734 | PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 5p13.1 | PTGER4 | |
5742 | PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 9q32-q33.3 | PTGS1 | |
5743 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 1q25.2-q25.3 | PTGS2 | |
5741 | PTH | parathyroid hormone | 11p15.3-p15.1 | PTH | |
5747 | PTK2 | PTK2 protein tyrosine kinase 2 | 8q24-qter | PTK2 | |
5757 | PTMA | prothymosin, alpha | 2q35-q36 | PTMA | |
5763 | PTMS | parathymosin | 12p13 | PTMS | |
5764 | PTN | pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) | 7q33-q34 | PTN | |
5787 | PTPRB | protein tyrosine phosphatase, receptor type, B | 12q15-q21 | PTPRB | |
5798 | PTPRN | protein tyrosine phosphatase, receptor type, N | 2q35-q36.1 | PTPRN | |
5805 | PTS | 6-pyruvoyltetrahydropterin synthase | 11q22.3-q23.3 | PTS | |
5817 | PVR | poliovirus receptor | 19q13.2 | PVR | |
5818 | PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 11q23.3 | PVRL1 | |
5697 | PYY | peptide YY | 17q21.1 | PYY | |
5858 | PZP | pregnancy-zone protein | 12p13-p12.2 | PZP | |
5860 | QDPR | quinoid dihydropteridine reductase | 4p15.31 | QDPR | |
10890 | RAB10 | RAB10, member RAS oncogene family | 2p23.3 | RAB10 | |
81876 | RAB1B | RAB1B, member RAS oncogene family | 11q12 | RAB1B | |
5864 | RAB3A | RAB3A, member RAS oncogene family | 19p13.2 | RAB3A | |
5865 | RAB3B | RAB3B, member RAS oncogene family | 1p32-p31 | RAB3B | |
5879 | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 7p22 | RAC1 | |
5881 | RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 17q25.3 | RAC3 | |
5810 | RAD1 | RAD1 homolog (S. pombe) | 5p13.2 | RAD1 | |
5893 | RAD52 | RAD52 homolog (S. cerevisiae) | 12p13-p12.2 | RAD52 | |
5896 | RAG1 | recombination activating gene 1 | 11p13 | RAG1 | |
5897 | RAG2 | recombination activating gene 2 | 11p13 | RAG2 | |
5891 | RAGE | renal tumor antigen | 14q32 | RAGE | |
5901 | RAN | RAN, member RAS oncogene family | 12q24.3 | RAN | |
5914 | RARA | retinoic acid receptor, alpha | 17q21 | RARA | |
5917 | RARS | arginyl-tRNA synthetase | 5q35.1 | RARS | |
9770 | RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 | 20pter-p12.1 | RASSF2 | |
30062 | RAX | retina and anterior neural fold homeobox | 18q21.32 | RAX | |
5925 | RB1 | retinoblastoma 1 (including osteosarcoma) | 13q14.2 | RB1 | |
5931 | RBBP7 | retinoblastoma binding protein 7 | Xp22.2 | RBBP7 | |
5935 | RBM3 | RNA binding motif (RNP1, RRM) protein 3 | Xp11.2 | RBM3 | |
5947 | RBP1 | retinol binding protein 1, cellular | 3q23 | RBP1 | |
5950 | RBP4 | retinol binding protein 4, plasma | 10q23-q24 | RBP4 | |
157506 | RDH10 | retinol dehydrogenase 10 (all-trans) | 8q21.11 | RDH10 | |
51109 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 14q24.1 | RDH11 | |
145226 | RDH12 | retinol dehydrogenase 12 (all-trans/9-cis/11-cis) | 14q24.1 | RDH12 | |
5959 | RDH5 | retinol dehydrogenase 5 (11-cis/9-cis) | 12q13-q14 | RDH5 | |
50700 | RDH8 | retinol dehydrogenase 8 (all-trans) | 19p13.2-p13.3 | RDH8 | |
5962 | RDX | radixin | 11q23 | RDX | |
8434 | RECK | reversion-inducing-cysteine-rich protein with kazal motifs | 9p13-p12 | RECK | |
9401 | RECQL4 | RecQ protein-like 4 | 8q24.3 | RECQL4 | |
5966 | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 2p13-p12 | REL | |
5970 | RELA | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 11q13 | RELA | |
5972 | REN | renin | 1q32 | REN | |
5979 | RET | ret proto-oncogene | 10q11.2 | RET | |
5981 | RFC1 | replication factor C (activator 1) 1, 145kDa | 4p14-p13 | RFC1 | |
6004 | RGS16 | regulator of G-protein signaling 16 | 1q25-q31 | RGS16 | |
5997 | RGS2 | regulator of G-protein signaling 2, 24kDa | 1q31 | RGS2 | |
5999 | RGS4 | regulator of G-protein signaling 4 | 1q23.3 | RGS4 | |
8787 | RGS9 | regulator of G-protein signaling 9 | 17q23-q24 | RGS9 | |
6007 | RHD | Rh blood group, D antigen | 1p36.11 | RHD | |
6010 | RHO | rhodopsin | 3q21-q24 | RHO | |
387 | RHOA | ras homolog gene family, member A | 3p21.3 | RHOA | |
388 | RHOB | ras homolog gene family, member B | 2p24 | RHOB | |
389 | RHOC | ras homolog gene family, member C | 1p13.1 | RHOC | |
55183 | RIF1 | RAP1 interacting factor homolog (yeast) | 2q23.3 | RIF1 | |
6017 | RLBP1 | retinaldehyde binding protein 1 | 15q26 | RLBP1 | |
6018 | RLF | rearranged L-myc fusion | 1p32 | RLF | |
390 | RND3 | Rho family GTPase 3 | 2q23.3 | RND3 | |
64320 | RNF25 | ring finger protein 25 | 2q35 | RNF25 | |
6098 | ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 6q22 | ROS1 | |
6101 | RP1 | retinitis pigmentosa 1 (autosomal dominant) | 8q11-q13 | RP1 | |
6118 | RPA2 | replication protein A2, 32kDa | 1p35 | RPA2 | |
29935 | RPA4 | replication protein A4, 34kDa | Xq21.33 | RPA4 | |
6120 | RPE | ribulose-5-phosphate-3-epimerase | 2q32-q33.3 | RPE | |
6121 | RPE65 | retinal pigment epithelium-specific protein 65kDa | 1p31 | RPE65 | |
22934 | RPIA | ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase) | 2p11.2 | RPIA | |
6134 | RPL10 | ribosomal protein L10 | Xq28 | RPL10 | |
6130 | RPL7A | ribosomal protein L7a | 9q34 | RPL7A | |
6175 | RPLP0 | ribosomal protein, large, P0 | 12q24.2 | RPLP0 | |
6227 | RPS21 | ribosomal protein S21 | 20q13.3 | RPS21 | |
6188 | RPS3 | ribosomal protein S3 | 11q13.3-q13.5 | RPS3 | |
6193 | RPS5 | ribosomal protein S5 | 19q13.4 | RPS5 | |
6194 | RPS6 | ribosomal protein S6 | 9p21 | RPS6 | |
3921 | RPSA | ribosomal protein SA | 3p22.2 | RPSA | |
6237 | RRAS | related RAS viral (r-ras) oncogene homolog | 19q13.3-qter | RRAS | |
10692 | RRH | retinal pigment epithelium-derived rhodopsin homolog | 4q25 | RRH | |
6247 | RS1 | retinoschisis (X-linked, juvenile) 1 | Xp22.2-p22.1 | RS1 | |
51773 | RSF1 | remodeling and spacing factor 1 | 11q14.1 | RSF1 | |
6252 | RTN1 | reticulon 1 | 14q23.1 | RTN1 | |
860 | RUNX2 | runt-related transcription factor 2 | 6p21 | RUNX2 | |
6257 | RXRB | retinoid X receptor, beta | 6p21.3 | RXRB | |
6261 | RYR1 | ryanodine receptor 1 (skeletal) | 19q13.1 | RYR1 | |
6273 | S100A2 | S100 calcium binding protein A2 | 1q21 | S100A2 | |
6279 | S100A8 | S100 calcium binding protein A8 | 1q21 | S100A8 | |
6280 | S100A9 | S100 calcium binding protein A9 | 1q21 | S100A9 | |
6285 | S100B | S100 calcium binding protein B | 21q22.3 | S100B | |
6267 | S11 | surface antigen (X-linked) 2 | Xq26-q28 | S11 | |
6268 | S12 | surface antigen (X-linked) 3 | - | S12 | |
6289 | SAA2 | serum amyloid A2 | 11p15.1-p14 | SAA2 | |
26278 | SACS | spastic ataxia of Charlevoix-Saguenay (sacsin) | 13q12 | SACS | |
6295 | SAG | S-antigen; retina and pineal gland (arrestin) | 2q37.1 | SAG | |
6301 | SARS | seryl-tRNA synthetase | 1p13.3-p13.1 | SARS | |
6304 | SATB1 | SATB homeobox 1 | 3p23 | SATB1 | |
22937 | SCAP | SREBF chaperone | 3p21.31 | SCAP | |
6319 | SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 10q23-q24 | SCD | |
652070 | SCFV | - | - | SCFV | |
6330 | SCN4B | sodium channel, voltage-gated, type IV, beta | 11q23.3 | SCN4B | |
6341 | SCO1 | SCO cytochrome oxidase deficient homolog 1 (yeast) | 17p12-p13 | SCO1 | |
9997 | SCO2 | SCO cytochrome oxidase deficient homolog 2 (yeast) | 22q13.33 | SCO2 | |
6342 | SCP2 | sterol carrier protein 2 | 1p32 | SCP2 | |
11341 | SCRG1 | - | 4q31-q32 | SCRG1 | |
6343 | SCT | secretin | 11p15.5 | SCT | |
6382 | SDC1 | syndecan 1 | 2p24.1 | SDC1 | |
6389 | SDHA | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | 5p15 | SDHA | |
6390 | SDHB | succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | 1p36.1-p35 | SDHB | |
10993 | SDS | serine dehydratase | 12q24.13 | SDS | |
6401 | SELE | selectin E (endothelial adhesion molecule 1) | 1q22-q25 | SELE | |
6402 | SELL | selectin L (lymphocyte adhesion molecule 1) | 1q23-q25 | SELL | |
6403 | SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 1q22-q25 | SELP | |
12 | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 14q32.1 | SERPINA3 | |
7536 | SF1 | splicing factor 1 | 11q13 | SF1 | |
2810 | SFN | stratifin | 1p36.11 | SFN | |
8910 | SGCE | sarcoglycan, epsilon | 7q21-q22 | SGCE | |
6446 | SGK1 | serum/glucocorticoid regulated kinase 1 | 6q23 | SGK1 | |
6462 | SHBG | sex hormone-binding globulin | 17p13-p12 | SHBG | |
56961 | SHD | Src homology 2 domain containing transforming protein D | 19p13.3 | SHD | |
90525 | SHF | Src homology 2 domain containing F | 15q21.1 | SHF | |
6469 | SHH | sonic hedgehog homolog (Drosophila) | 7q36 | SHH | |
6476 | SI | sucrase-isomaltase (alpha-glucosidase) | 3q25.2-q26.2 | SI | |
8487 | SIP1 | survival of motor neuron protein interacting protein 1 | 14q13 | SIP1 | |
23411 | SIRT1 | sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae) | 10q21.3 | SIRT1 | |
6497 | SKI | v-ski sarcoma viral oncogene homolog (avian) | 1q22-q24 | SKI | |
51763 | SKIP | - | 17p13.3 | SKIP | |
6500 | SKP1 | S-phase kinase-associated protein 1 | 5q31 | SKP1 | |
6502 | SKP2 | S-phase kinase-associated protein 2 (p45) | 5p13 | SKP2 | |
6503 | SLA | Src-like-adaptor | 8q22.3-qter|8q24 | SLA | |
4891 | SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 | 12q13 | SLC11A2 | |
6559 | SLC12A3 | solute carrier family 12 (sodium/chloride transporters), member 3 | 16q13 | SLC12A3 | |
57084 | SLC17A6 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 | 11p14.3 | SLC17A6 | |
57030 | SLC17A7 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 | 19q13 | SLC17A7 | |
6571 | SLC18A2 | solute carrier family 18 (vesicular monoamine), member 2 | 10q25 | SLC18A2 | |
6506 | SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 11p13-p12 | SLC1A2 | |
116085 | SLC22A12 | solute carrier family 22 (organic anion/urate transporter), member 12 | 11q13.1 | SLC22A12 | |
6583 | SLC22A4 | solute carrier family 22 (organic cation/ergothioneine transporter), member 4 | 5q31.1 | SLC22A4 | |
6519 | SLC3A1 | solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1 | 2p16.3 | SLC3A1 | |
30061 | SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 | 2q32 | SLC40A1 | |
6521 | SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 17q21-q22 | SLC4A1 | |
9497 | SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 | 3p22 | SLC4A7 | |
6530 | SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 16q12.2 | SLC6A2 | |
6531 | SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 5p15.3 | SLC6A3 | |
6532 | SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 17q11.1-q12 | SLC6A4 | |
9152 | SLC6A5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 11p15.2-p15.1 | SLC6A5 | |
6588 | SLN | sarcolipin | 11q22-q23 | SLN | |
4086 | SMAD1 | SMAD family member 1 | 4q31 | SMAD1 | |
4087 | SMAD2 | SMAD family member 2 | 18q21.1 | SMAD2 | |
4088 | SMAD3 | SMAD family member 3 | 15q22.33 | SMAD3 | |
4089 | SMAD4 | SMAD family member 4 | 18q21.1 | SMAD4 | |
4092 | SMAD7 | SMAD family member 7 | 18q21.1 | SMAD7 | |
6595 | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 9p22.3 | SMARCA2 | |
56916 | SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 4q22-q23 | SMARCAD1 | |
6611 | SMS | spermine synthase | Xp22.1 | SMS | |
6622 | SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 4q21 | SNCA | |
80725 | SNIP | - | 17q12 | SNIP | |
8651 | SOCS1 | suppressor of cytokine signaling 1 | 16p13.13 | SOCS1 | |
9021 | SOCS3 | suppressor of cytokine signaling 3 | 17q25.3 | SOCS3 | |
6647 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 21q22.1|21q22.11 | SOD1 | |
6648 | SOD2 | superoxide dismutase 2, mitochondrial | 6q25.3 | SOD2 | |
6649 | SOD3 | superoxide dismutase 3, extracellular | 4p15.3-p15.1 | SOD3 | |
6651 | SON | SON DNA binding protein | 21q22.1-q22.2|21q22.11 | SON | |
6652 | SORD | sorbitol dehydrogenase | 15q15.3 | SORD | |
64321 | SOX17 | SRY (sex determining region Y)-box 17 | 8q11.23 | SOX17 | |
6657 | SOX2 | SRY (sex determining region Y)-box 2 | 3q26.3-q27 | SOX2 | |
6658 | SOX3 | SRY (sex determining region Y)-box 3 | Xq27.1 | SOX3 | |
6662 | SOX9 | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | 17q24.3-q25.1 | SOX9 | |
6667 | SP1 | Sp1 transcription factor | 12q13.1 | SP1 | |
6668 | SP2 | Sp2 transcription factor | 17q21.32 | SP2 | |
6670 | SP3 | Sp3 transcription factor | 2q31 | SP3 | |
6671 | SP4 | Sp4 transcription factor | 7p15.3 | SP4 | |
389058 | SP5 | Sp5 transcription factor | 2q31.1 | SP5 | |
80320 | SP6 | Sp6 transcription factor | 17q21.32 | SP6 | |
121340 | SP7 | Sp7 transcription factor | 12q13.13 | SP7 | |
6678 | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 5q31.3-q32 | SPARC | |
6690 | SPINK1 | serine peptidase inhibitor, Kazal type 1 | 5q32 | SPINK1 | |
6693 | SPN | sialophorin (leukosialin, CD43) | 16p11.2 | SPN | |
6696 | SPP1 | secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 4q21-q25 | SPP1 | |
6697 | SPR | sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) | 2p14-p12 | SPR | |
6714 | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 20q12-q13 | SRC | |
6720 | SREBF1 | sterol regulatory element binding transcription factor 1 | 17p11.2 | SREBF1 | |
6722 | SRF | serum response factor (c-fos serum response element-binding transcription factor) | 6p21.1 | SRF | |
6717 | SRI | sorcin | 7q21.1 | SRI | |
6345 | SRL | sarcalumenin | 16p13.3 | SRL | |
6723 | SRM | spermidine synthase | 1p36-p22 | SRM | |
6725 | SRMS | src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | - | SRMS | |
6729 | SRP54 | signal recognition particle 54kDa | 14q13.2 | SRP54 | |
63826 | SRR | serine racemase | 17p13 | SRR | |
6736 | SRY | sex determining region Y | Yp11.3 | SRY | |
6741 | SSB | Sjogren syndrome antigen B (autoantigen La) | 2q31.1 | SSB | |
6750 | SST | somatostatin | 3q28 | SST | |
6751 | SSTR1 | somatostatin receptor 1 | 14q13 | SSTR1 | |
8027 | STAM | signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | 10p14-p13 | STAM | |
6770 | STAR | steroidogenic acute regulatory protein | 8p11.2 | STAR | |
6772 | STAT1 | signal transducer and activator of transcription 1, 91kDa | 2q32.2 | STAT1 | |
6773 | STAT2 | signal transducer and activator of transcription 2, 113kDa | 12q13.2 | STAT2 | |
6774 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 17q21.31 | STAT3 | |
6775 | STAT4 | signal transducer and activator of transcription 4 | 2q32.2-q32.3 | STAT4 | |
6776 | STAT5A | signal transducer and activator of transcription 5A | 17q11.2 | STAT5A | |
6777 | STAT5B | signal transducer and activator of transcription 5B | 17q11.2 | STAT5B | |
27067 | STAU2 | staufen, RNA binding protein, homolog 2 (Drosophila) | 8q13-q21.1 | STAU2 | |
246744 | STH | saitohin | 17q21.1 | STH | |
7955 | STL | - | 6q22.33 | STL | |
1177 | STN | statin | - | STN | |
346673 | STRA8 | stimulated by retinoic acid gene 8 homolog (mouse) | 7q33 | STRA8 | |
11171 | STRAP | serine/threonine kinase receptor associated protein | 12p12.3 | STRAP | |
412 | STS | steroid sulfatase (microsomal), isozyme S | Xp22.32 | STS | |
23673 | STX12 | syntaxin 12 | 1p35-p34.1 | STX12 | |
6804 | STX1A | syntaxin 1A (brain) | 7q11.23 | STX1A | |
112755 | STX1B | syntaxin 1B | 16p11.2 | STX1B | |
6812 | STXBP1 | syntaxin binding protein 1 | 9q34.1 | STXBP1 | |
10923 | SUB1 | SUB1 homolog (S. cerevisiae) | 5p13.3 | SUB1 | |
51684 | SUFU | suppressor of fused homolog (Drosophila) | 10q24.32 | SUFU | |
6817 | SULT1A1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 | 16p12.1 | SULT1A1 | |
6799 | SULT1A2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | 16p12.1 | SULT1A2 | |
6818 | SULT1A3 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 | 16p11.2 | SULT1A3 | |
27284 | SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 4q13.3 | SULT1B1 | |
6819 | SULT1C2 | sulfotransferase family, cytosolic, 1C, member 2 | 2q11.1-q11.2 | SULT1C2 | |
442038 | SULT1C3 | sulfotransferase family, cytosolic, 1C, member 3 | 2q12.3 | SULT1C3 | |
6783 | SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 4q13.1 | SULT1E1 | |
6822 | SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 19q13.3 | SULT2A1 | |
7341 | SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 2q33 | SUMO1 | |
6613 | SUMO2 | SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) | 17q25.1 | SUMO2 | |
6612 | SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 21q22.3 | SUMO3 | |
6850 | SYK | spleen tyrosine kinase | 9q22 | SYK | |
8224 | SYN3 | synapsin III | 22q12.3 | SYN3 | |
6855 | SYP | synaptophysin | Xp11.23-p11.22 | SYP | |
6870 | TACR3 | tachykinin receptor 3 | 4q25 | TACR3 | |
6886 | TAL1 | T-cell acute lymphocytic leukemia 1 | 1p32 | TAL1 | |
6897 | TARS | threonyl-tRNA synthetase | 5p13.2 | TARS | |
83756 | TAS1R3 | taste receptor, type 1, member 3 | 1p36.33 | TAS1R3 | |
50833 | TAS2R16 | taste receptor, type 2, member 16 | 7q31.1-q31.3|7q31 | TAS2R16 | |
5726 | TAS2R38 | taste receptor, type 2, member 38 | 7q34 | TAS2R38 | |
6898 | TAT | tyrosine aminotransferase | 16q22.1 | TAT | |
30851 | TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 17p13 | TAX1BP3 | |
6901 | TAZ | tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) | Xq28 | TAZ | |
6902 | TBCA | tubulin folding cofactor A | 5q14.1 | TBCA | |
6908 | TBP | TATA box binding protein | 6q27 | TBP | |
50945 | TBX22 | T-box 22 | Xq21.1 | TBX22 | |
6926 | TBX3 | T-box 3 (ulnar mammary syndrome) | 12q24.1 | TBX3 | |
6910 | TBX5 | T-box 5 | 12q24.1 | TBX5 | |
6938 | TCF12 | transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) | 15q21 | TCF12 | |
100038246 | TD1 | - | - | TD1 | |
403078 | TDF | - | - | TDF | |
6996 | TDG | thymine-DNA glycosylase | 12q24.1 | TDG | |
6999 | TDO2 | tryptophan 2,3-dioxygenase | 4q31-q32 | TDO2 | |
7007 | TECTA | tectorin alpha | 11q22-q24 | TECTA | |
7008 | TEF | thyrotrophic embryonic factor | 22q13|22q13.2 | TEF | |
7010 | TEK | TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) | 9p21 | TEK | |
374739 | TEPP | - | 16q13 | TEPP | |
7015 | TERT | telomerase reverse transcriptase | 5p15.33 | TERT | |
26136 | TES | testis derived transcript (3 LIM domains) | 7q31.2 | TES | |
7018 | TF | transferrin | 3q22.1 | TF | |
7029 | TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 3q23 | TFDP2 | |
7942 | TFEB | transcription factor EB | 6p21 | TFEB | |
7031 | TFF1 | trefoil factor 1 | 21q22.3 | TFF1 | |
7032 | TFF2 | trefoil factor 2 (spasmolytic protein 1) | 21q22.3 | TFF2 | |
7033 | TFF3 | trefoil factor 3 (intestinal) | 21q22.3 | TFF3 | |
10342 | TFG | TRK-fused gene | 3q12.2 | TFG | |
7036 | TFR2 | transferrin receptor 2 | 7q22 | TFR2 | |
7038 | TG | thyroglobulin | 8q24 | TG | |
7039 | TGFA | transforming growth factor, alpha | 2p13 | TGFA | |
7040 | TGFB1 | transforming growth factor, beta 1 | 19q13.2|19q13.1 | TGFB1 | |
7043 | TGFB3 | transforming growth factor, beta 3 | 14q24 | TGFB3 | |
7046 | TGFBR1 | transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa) | 9q22 | TGFBR1 | |
7052 | TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 20q12 | TGM2 | |
7054 | TH | tyrosine hydroxylase | 11p15.5 | TH | |
7058 | THBS2 | thrombospondin 2 | 6q27 | THBS2 | |
7070 | THY1 | Thy-1 cell surface antigen | 11q22.3-q23 | THY1 | |
7075 | TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 1p34-p33 | TIE1 | |
8914 | TIMELESS | timeless homolog (Drosophila) | 12q12-q13 | TIMELESS | |
7076 | TIMP1 | TIMP metallopeptidase inhibitor 1 | Xp11.3-p11.23 | TIMP1 | |
7077 | TIMP2 | TIMP metallopeptidase inhibitor 2 | 17q25 | TIMP2 | |
7079 | TIMP4 | TIMP metallopeptidase inhibitor 4 | 3p25 | TIMP4 | |
7083 | TK1 | thymidine kinase 1, soluble | 17q23.2-q25.3 | TK1 | |
7096 | TLR1 | toll-like receptor 1 | 4p14 | TLR1 | |
7097 | TLR2 | toll-like receptor 2 | 4q32 | TLR2 | |
7098 | TLR3 | toll-like receptor 3 | 4q35 | TLR3 | |
7099 | TLR4 | toll-like receptor 4 | 9q32-q33 | TLR4 | |
7100 | TLR5 | toll-like receptor 5 | 1q41-q42 | TLR5 | |
10333 | TLR6 | toll-like receptor 6 | 4p14 | TLR6 | |
51284 | TLR7 | toll-like receptor 7 | Xp22.3 | TLR7 | |
54106 | TLR9 | toll-like receptor 9 | 3p21.3 | TLR9 | |
3371 | TNC | tenascin C (hexabrachion) | 9q33 | TNC | |
7124 | TNF | tumor necrosis factor (TNF superfamily, member 2) | 6p21.3 | TNF | |
8797 | TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 8p21 | TNFRSF10A | |
7132 | TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 12p13.2 | TNFRSF1A | |
7150 | TOP1 | topoisomerase (DNA) I | 20q12-q13.1 | TOP1 | |
9760 | TOX | thymocyte selection-associated high mobility group box | 8q12.1 | TOX | |
7157 | TP53 | tumor protein p53 | 17p13.1 | TP53 | |
7166 | TPH1 | tryptophan hydroxylase 1 (tryptophan 5-monooxygenase) | 11p15.3-p14 | TPH1 | |
121278 | TPH2 | tryptophan hydroxylase 2 | 12q21.1 | TPH2 | |
7167 | TPI1 | triosephosphate isomerase 1 | 12p13 | TPI1 | |
27010 | TPK1 | thiamin pyrophosphokinase 1 | 7q34-q35 | TPK1 | |
7168 | TPM1 | tropomyosin 1 (alpha) | 15q22.1 | TPM1 | |
7172 | TPMT | thiopurine S-methyltransferase | 6p22.3 | TPMT | |
7173 | TPO | thyroid peroxidase | 2p25 | TPO | |
11076 | TPPP | tubulin polymerization promoting protein | 5p15.3 | TPPP | |
7175 | TPR | translocated promoter region (to activated MET oncogene) | 1q25 | TPR | |
8717 | TRADD | TNFRSF1A-associated via death domain | 16q22 | TRADD | |
7187 | TRAF3 | TNF receptor-associated factor 3 | 14q32.32 | TRAF3 | |
7188 | TRAF5 | TNF receptor-associated factor 5 | 1q32 | TRAF5 | |
7189 | TRAF6 | TNF receptor-associated factor 6 | 11p12 | TRAF6 | |
23471 | TRAM1 | translocation associated membrane protein 1 | 8q13.3 | TRAM1 | |
7183 | TRC | transfer RNA cysteine | - | TRC | |
7200 | TRH | thyrotropin-releasing hormone | 3q13.3-q21 | TRH | |
7204 | TRIO | triple functional domain (PTPRF interacting) | 5p15.1-p14 | TRIO | |
7216 | TRO | trophinin | Xp11.22-p11.21 | TRO | |
8989 | TRPA1 | transient receptor potential cation channel, subfamily A, member 1 | 8q13 | TRPA1 | |
7226 | TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 21q22.3 | TRPM2 | |
29850 | TRPM5 | transient receptor potential cation channel, subfamily M, member 5 | 11p15.5 | TRPM5 | |
79054 | TRPM8 | transient receptor potential cation channel, subfamily M, member 8 | 2q37.1 | TRPM8 | |
7442 | TRPV1 | transient receptor potential cation channel, subfamily V, member 1 | 17p13.3 | TRPV1 | |
51393 | TRPV2 | transient receptor potential cation channel, subfamily V, member 2 | 17p11.2 | TRPV2 | |
162514 | TRPV3 | transient receptor potential cation channel, subfamily V, member 3 | 17p13.3 | TRPV3 | |
59341 | TRPV4 | transient receptor potential cation channel, subfamily V, member 4 | 12q24.1 | TRPV4 | |
7248 | TSC1 | tuberous sclerosis 1 | 9q34 | TSC1 | |
7249 | TSC2 | tuberous sclerosis 2 | 16p13.3 | TSC2 | |
7251 | TSG101 | tumor susceptibility gene 101 | 11p15 | TSG101 | |
790953 | TSL | - | - | TSL | |
7247 | TSN | translin | 2q21.1 | TSN | |
7263 | TST | thiosulfate sulfurtransferase (rhodanese) | 22q13.1 | TST | |
54970 | TTC12 | tetratricopeptide repeat domain 12 | 11q23.1 | TTC12 | |
7272 | TTK | TTK protein kinase | 6q13-q21 | TTK | |
150465 | TTL | tubulin tyrosine ligase | 2q13 | TTL | |
645369 | TTMA | - | 18p11.31 | TTMA | |
7273 | TTN | titin | 2q31 | TTN | |
7276 | TTR | transthyretin (prealbumin, amyloidosis type I) | 18q12.1 | TTR | |
7275 | TUB | tubby homolog (mouse) | 11p15.5 | TUB | |
203068 | TUBB | tubulin, beta | 6p21.33 | TUBB | |
56995 | TULP4 | tubby like protein 4 | 6q25-q26 | TULP4 | |
7295 | TXN | thioredoxin | 9q31 | TXN | |
7297 | TYK2 | tyrosine kinase 2 | 19p13.2 | TYK2 | |
7298 | TYMS | thymidylate synthetase | 18p11.32 | TYMS | |
7299 | TYR | tyrosinase (oculocutaneous albinism IA) | 11q14-q21 | TYR | |
7317 | UBA1 | ubiquitin-like modifier activating enzyme 1 | Xp11.23 | UBA1 | |
10054 | UBA2 | ubiquitin-like modifier activating enzyme 2 | 19q12 | UBA2 | |
9039 | UBA3 | ubiquitin-like modifier activating enzyme 3 | 3p24.3-p13 | UBA3 | |
7314 | UBB | ubiquitin B | 17p12-p11.2 | UBB | |
7316 | UBC | ubiquitin C | 12q24.3 | UBC | |
7345 | UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 4p14 | UCHL1 | |
7349 | UCN | urocortin | 2p23-p21 | UCN | |
7350 | UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 4q28-q31 | UCP1 | |
7351 | UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 11q13 | UCP2 | |
54658 | UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | 2q37 | UGT1A1 | |
54657 | UGT1A4 | UDP glucuronosyltransferase 1 family, polypeptide A4 | 2q37 | UGT1A4 | |
54579 | UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | 2q37 | UGT1A5 | |
54578 | UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | 2q37 | UGT1A6 | |
54577 | UGT1A7 | UDP glucuronosyltransferase 1 family, polypeptide A7 | 2q37 | UGT1A7 | |
54576 | UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | 2q37 | UGT1A8 | |
7364 | UGT2B7 | UDP glucuronosyltransferase 2 family, polypeptide B7 | 4q13 | UGT2B7 | |
7369 | UMOD | uromodulin (uromucoid, Tamm-Horsfall glycoprotein) | 16p12.3 | UMOD | |
7374 | UNG | uracil-DNA glycosylase | 12q23-q24.1 | UNG | |
85451 | UNK | unkempt homolog (Drosophila) | 17q25.1 | UNK | |
151531 | UPP2 | uridine phosphorylase 2 | 2q24.1 | UPP2 | |
7389 | UROD | uroporphyrinogen decarboxylase | 1p34 | UROD | |
10090 | UST | uronyl-2-sulfotransferase | 6q25.1 | UST | |
6844 | VAMP2 | vesicle-associated membrane protein 2 (synaptobrevin 2) | 17p13.1 | VAMP2 | |
7407 | VARS | valyl-tRNA synthetase | 6p21.3 | VARS | |
25806 | VAX2 | ventral anterior homeobox 2 | 2p13 | VAX2 | |
7414 | VCL | vinculin | 10q22.1-q23 | VCL | |
7415 | VCP | valosin-containing protein | 9p13.3 | VCP | |
7416 | VDAC1 | voltage-dependent anion channel 1 | 5q31 | VDAC1 | |
7421 | VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 12q13.11 | VDR | |
7422 | VEGFA | vascular endothelial growth factor A | 6p12 | VEGFA | |
7428 | VHL | von Hippel-Lindau tumor suppressor | 3p26-p25 | VHL | |
50853 | VILL | villin-like | 3p21.3 | VILL | |
7431 | VIM | vimentin | 10p13 | VIM | |
7432 | VIP | vasoactive intestinal peptide | 6q25 | VIP | |
57506 | VISA | - | 20p13 | VISA | |
5212 | VIT | vitrin | 2p22-p21 | VIT | |
8876 | VNN1 | vanin 1 | 6q23-q24 | VNN1 | |
55823 | VPS11 | vacuolar protein sorting 11 homolog (S. cerevisiae) | 11q23 | VPS11 | |
55737 | VPS35 | vacuolar protein sorting 35 homolog (S. cerevisiae) | 16q12 | VPS35 | |
7450 | VWF | von Willebrand factor | 12p13.3 | VWF | |
51322 | WAC | WW domain containing adaptor with coiled-coil | - | WAC | |
7453 | WARS | tryptophanyl-tRNA synthetase | 14q32.31 | WARS | |
57590 | WDFY1 | WD repeat and FYVE domain containing 1 | 2q36.1 | WDFY1 | |
7465 | WEE1 | WEE1 homolog (S. pombe) | 11p15.3-p15.1 | WEE1 | |
7471 | WNT1 | wingless-type MMTV integration site family, member 1 | 12q13 | WNT1 | |
7480 | WNT10B | wingless-type MMTV integration site family, member 10B | 12q13 | WNT10B | |
7474 | WNT5A | wingless-type MMTV integration site family, member 5A | 3p21-p14 | WNT5A | |
51741 | WWOX | WW domain containing oxidoreductase | 16q23.3-q24.1 | WWOX | |
7494 | XBP1 | X-box binding protein 1 | 22q12.1|22q12 | XBP1 | |
7498 | XDH | xanthine dehydrogenase | 2p23.1 | XDH | |
331 | XIAP | X-linked inhibitor of apoptosis | Xq25 | XIAP | |
7507 | XPA | xeroderma pigmentosum, complementation group A | 9q22.3 | XPA | |
7508 | XPC | xeroderma pigmentosum, complementation group C | 3p25 | XPC | |
7514 | XPO1 | exportin 1 (CRM1 homolog, yeast) | 2p16 | XPO1 | |
7515 | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 | 19q13.2 | XRCC1 | |
7516 | XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | 7q36.1 | XRCC2 | |
7517 | XRCC3 | X-ray repair complementing defective repair in Chinese hamster cells 3 | 14q32.3 | XRCC3 | |
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 5q13-q14 | XRCC4 | |
7520 | XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa) | 2q35 | XRCC5 | |
9942 | XYLB | xylulokinase homolog (H. influenzae) | 3p22-p21.3 | XYLB | |
64131 | XYLT1 | xylosyltransferase I | 16p12.3 | XYLT1 | |
10413 | YAP1 | Yes-associated protein 1, 65kDa | 11q13 | YAP1 | |
7533 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 22q12.3 | YWHAH | |
7528 | YY1 | YY1 transcription factor | 14q | YY1 | |
51776 | ZAK | - | 2q24.2 | ZAK | |
7535 | ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 2q12 | ZAP70 | |
6935 | ZEB1 | zinc finger E-box binding homeobox 1 | 10p11.2 | ZEB1 | |
9839 | ZEB2 | zinc finger E-box binding homeobox 2 | 2q22 | ZEB2 | |
85416 | ZIC5 | Zic family member 5 (odd-paired homolog, Drosophila) | 13q32.3 | ZIC5 | |
7692 | ZNF133 | zinc finger protein 133 | 20p11.23-p11.22 | ZNF133 | |
7701 | ZNF142 | zinc finger protein 142 | 2q34-q35 | ZNF142 | |
374879 | ZNF699 | zinc finger protein 699 | 19p13.2 | ZNF699 | |
22917 | ZP1 | zona pellucida glycoprotein 1 (sperm receptor) | 11q12.2 | ZP1 | |
145482 | PTGR2 | prostaglandin reductase 2 | 14q24.3 | ZADH1 |